{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "\"\"\" this scripts run the analysis for comparing QTL studies, tissues together with therapy areas matched\"\"\"\n",
    "\n",
    "# from functions import relative_success, spreadSheetFormatter\n",
    "# from stoppedTrials import terminated_td\n",
    "# from DoEAssessment import directionOfEffect\n",
    "# from membraneTargets import target_membrane\n",
    "from pyspark.sql import SparkSession, Window\n",
    "import pyspark.sql.functions as F\n",
    "from datetime import datetime\n",
    "from datetime import date\n",
    "from pyspark.sql.types import StructType, StructField, StringType, IntegerType\n",
    "from pyspark.sql.types import (\n",
    "    StructType,\n",
    "    StructField,\n",
    "    DoubleType,\n",
    "    DecimalType,\n",
    "    StringType,\n",
    "    FloatType,\n",
    ")\n",
    "\n",
    "spark = SparkSession.builder.getOrCreate()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 11:>                                                         (0 + 1) / 1]\r"
     ]
    }
   ],
   "source": [
    "platform_v = \"24.09\"\n",
    "\n",
    "chembl = spark.read.parquet(\n",
    "    f\"gs://open-targets-data-releases/{platform_v}/output/etl/parquet/evidence/sourceId=chembl\"\n",
    ")\n",
    "\n",
    "target_path = (\n",
    "    f\"gs://open-targets-data-releases/{platform_v}/output/etl/parquet/targets/\"\n",
    ")\n",
    "target = spark.read.parquet(target_path)\n",
    "\n",
    "path_s25 = \"gs://ot-team/jroldan/GIR_S01.csv\"\n",
    "nelson = spark.read.csv(path_s25, header=True)\n",
    "\n",
    "path_mapping = \"gs://ot-team/jroldan/mappings.csv\"\n",
    "mapping = spark.read.csv(path_mapping, header=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------+---------------------------------+------+------------------+--------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+--------------------+------------+----------+--------------------+--------------------+----------+------------+------+-------------+---------+--------+-----------+----------+-----------+---------+------+--------------------+---------------+------------------+------------+------------+-----------+----------------+------+-----------+------+\n",
      "|       ti_uid|indication_association_similarity|target|indication_mesh_id|indication_mesh_term|historical_max_phase|active_max_phase|combined_max_phase|succ_p_1|succ_1_2|succ_2_3|succ_3_a|orphan|year_launch|assoc_mesh_id|     assoc_mesh_term|assoc_source|assoc_info|      original_trait|       original_link|assoc_year|pic_qtl_pval|pic_h4|af_gnomad_nfe|l2g_share|l2g_rank|assoc_share|assoc_rank|source_name| abs_beta|abs_or|               areas|genetic_insight|     target_status|ab_tractable|sm_tractable|rhodop_gpcr|nuclear_receptor|enzyme|ion_channel|kinase|\n",
      "+-------------+---------------------------------+------+------------------+--------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+--------------------+------------+----------+--------------------+--------------------+----------+------------+------+-------------+---------+--------+-----------+----------+-----------+---------+------+--------------------+---------------+------------------+------------+------------+-----------+----------------+------+-----------+------+\n",
      "|  A2M-D002545|                            0.368|   A2M|           D002545|      Brain Ischemia|           Phase III|            null|         Phase III|    TRUE|    TRUE|    TRUE|   FALSE|  TRUE|       null|      D054222|Cobblestone Lisse...|         OTG|      null|  Cortical thickness|https://genetics....|      2021|        null|  null|  0.512621991|     0.82|       1|       0.82|         1|       GWAS|     null|  null|neurology, cardio...|      omim/tcga|unsupported target|        TRUE|        TRUE|      FALSE|           FALSE| FALSE|      FALSE| FALSE|\n",
      "|  A2M-D010003|                            0.235|   A2M|           D010003|      Osteoarthritis|         Preclinical|            null|       Preclinical|   FALSE|    null|    null|    null| FALSE|       null|      D054222|Cobblestone Lisse...|         OTG|      null|  Cortical thickness|https://genetics....|      2021|        null|  null|  0.512621991|     0.82|       1|       0.82|         1|       GWAS|     null|  null|     musculoskeletal|           both|unsupported target|        TRUE|        TRUE|      FALSE|           FALSE| FALSE|      FALSE| FALSE|\n",
      "|  A2M-D016491|                            0.198|   A2M|           D016491|Peripheral Vascul...|           Phase III|            null|         Phase III|    TRUE|    TRUE|    TRUE|   FALSE|  TRUE|       null|      D054222|Cobblestone Lisse...|         OTG|      null|  Cortical thickness|https://genetics....|      2021|        null|  null|  0.512621991|     0.82|       1|       0.82|         1|       GWAS|     null|  null|      cardiovascular|           both|unsupported target|        TRUE|        TRUE|      FALSE|           FALSE| FALSE|      FALSE| FALSE|\n",
      "|  A2M-D020521|                            0.381|   A2M|           D020521|              Stroke|           Phase III|            null|         Phase III|    TRUE|    TRUE|    TRUE|   FALSE|  TRUE|       null|      D054222|Cobblestone Lisse...|         OTG|      null|  Cortical thickness|https://genetics....|      2021|        null|  null|  0.512621991|     0.82|       1|       0.82|         1|       GWAS|     null|  null|neurology, cardio...|           gwas|unsupported target|        TRUE|        TRUE|      FALSE|           FALSE| FALSE|      FALSE| FALSE|\n",
      "|AADAT-D012559|                            0.602| AADAT|           D012559|       Schizophrenia|         Preclinical|            null|       Preclinical|   FALSE|    null|    null|    null| FALSE|       null|      D012893|Sleep Wake Disorders|         OTG|      null|Ease of getting u...|https://genetics....|      2019|        null|  null|  0.097496108|     0.89|       1|       0.89|         1|       GWAS|     null|  null|          psychiatry|           both|unsupported target|        TRUE|        TRUE|      FALSE|           FALSE| FALSE|      FALSE| FALSE|\n",
      "| AAK1-D009437|                            0.235|  AAK1|           D009437|           Neuralgia|                null|        Phase II|          Phase II|    TRUE|    TRUE|    null|    null| FALSE|       null|      D006402|Hematologic Diseases|         OTG|      null|   Hemoglobin levels|https://genetics....|      2021|        null|  null|  0.114700921|     0.77|       1|       0.77|         1|       GWAS|0.0202474|  null|neurology, signs/...|           both|unsupported target|        TRUE|        TRUE|      FALSE|           FALSE| FALSE|      FALSE|  TRUE|\n",
      "| AAK1-D051474|                            0.221|  AAK1|           D051474|Neuralgia, Posthe...|                null|        Phase II|          Phase II|    TRUE|    TRUE|    null|    null| FALSE|       null|      D006402|Hematologic Diseases|         OTG|      null|   Hemoglobin levels|https://genetics....|      2021|        null|  null|  0.114700921|     0.77|       1|       0.77|         1|       GWAS|0.0202474|  null|neurology, signs/...|           gwas|unsupported target|        TRUE|        TRUE|      FALSE|           FALSE| FALSE|      FALSE|  TRUE|\n",
      "| ABAT-D000544|                            0.218|  ABAT|           D000544|   Alzheimer Disease|            Phase II|            null|          Phase II|    TRUE|    TRUE|   FALSE|    null| FALSE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|neurology, psychi...|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D000690|                            0.438|  ABAT|           D000690|Amyotrophic Later...|         Preclinical|            null|       Preclinical|   FALSE|    null|    null|    null| FALSE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|neurology, metabolic|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D004827|                            0.226|  ABAT|           D004827|            Epilepsy|                null|     Preclinical|       Preclinical|    null|    null|    null|    null|  TRUE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|           neurology|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D004828|                            0.201|  ABAT|           D004828| Epilepsies, Partial|         Preclinical|            null|       Preclinical|   FALSE|    null|    null|    null|  TRUE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|           neurology|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D005600|                            0.331|  ABAT|           D005600|  Fragile X Syndrome|                null|     Preclinical|       Preclinical|    null|    null|    null|    null| FALSE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|neurology, congen...|      omim/tcga|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D005879|                            0.355|  ABAT|           D005879|   Tourette Syndrome|            Phase II|            null|          Phase II|    TRUE|    TRUE|   FALSE|    null|  TRUE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|neurology, congen...|      omim/tcga|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D009103|                            0.222|  ABAT|           D009103|  Multiple Sclerosis|         Preclinical|            null|       Preclinical|   FALSE|    null|    null|    null|  TRUE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|   neurology, immune|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D009293|                            0.201|  ABAT|           D009293|Opioid-Related Di...|         Preclinical|            null|       Preclinical|   FALSE|    null|    null|    null|  TRUE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|          psychiatry|           gwas|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D009437|                            0.206|  ABAT|           D009437|           Neuralgia|                null|     Preclinical|       Preclinical|    null|    null|    null|    null|  TRUE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|neurology, signs/...|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D010300|                            0.464|  ABAT|           D010300|   Parkinson Disease|         Preclinical|            null|       Preclinical|   FALSE|    null|    null|    null|  TRUE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|           neurology|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D013036|                            0.213|  ABAT|           D013036|   Spasms, Infantile|            Launched|        Launched|          Launched|    TRUE|    TRUE|    TRUE|    TRUE|  TRUE|       2019|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|           neurology|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D013313|                            0.031|  ABAT|           D013313|Stress Disorders,...|         Preclinical|            null|       Preclinical|   FALSE|    null|    null|    null|  TRUE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|          psychiatry|           gwas|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "| ABAT-D014402|                            0.355|  ABAT|           D014402|  Tuberous Sclerosis|                null|     Preclinical|       Preclinical|    null|    null|    null|    null| FALSE|       null|      D000592|Amino Acid Metabo...|        OMIM|      null|GABA-transaminase...|https://omim.org/...|      null|        null|  null|         null|     null|    null|       null|      null|       OMIM|     null|  null|            oncology|           both|unsupported target|       FALSE|        TRUE|      FALSE|           FALSE|  TRUE|      FALSE| FALSE|\n",
      "+-------------+---------------------------------+------+------------------+--------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+--------------------+------------+----------+--------------------+--------------------+----------+------------+------+-------------+---------+--------+-----------+----------+-----------+---------+------+--------------------+---------------+------------------+------------+------------+-----------+----------------+------+-----------+------+\n",
      "only showing top 20 rows\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "24/09/26 10:39:15 WARN package: Truncated the string representation of a plan since it was too large. This behavior can be adjusted by setting 'spark.sql.debug.maxToStringFields'.\n",
      "                                                                                \r"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 11:>                                                         (0 + 1) / 1]\r"
     ]
    }
   ],
   "source": [
    "nelson.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "data": {
      "text/plain": [
       "2320"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 11:>                                                         (0 + 1) / 1]\r"
     ]
    }
   ],
   "source": [
    "mappings.count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 11:>                                                         (0 + 1) / 1]\r"
     ]
    }
   ],
   "source": [
    "### prepare mapping EFO-MeSH dataset  (#2,320 pairs)\n",
    "mappings = (\n",
    "    mapping.withColumn(\n",
    "        \"efo_column\",\n",
    "        F.regexp_replace(F.col(\"curie_id\"), \":\", \"_\"),  # Replaces \":\" with \"_\"\n",
    "    )\n",
    "    .withColumn(\n",
    "        \"mesh_column\",\n",
    "        F.regexp_replace(\n",
    "            F.col(\"mapped_curie\"), \"^MeSH:\", \"\"\n",
    "        ),  # Removes \"MeSH:\" from the start\n",
    "    )\n",
    "    .selectExpr(\"label\", \"efo_column\", \"mesh_column as indication_mesh_id\")\n",
    ")\n",
    "### Get csv from Nelson and join bring EFO column to MeSH terms\n",
    "nelson_efo = (\n",
    "    nelson.join(mappings, on=\"indication_mesh_id\", how=\"left\")\n",
    "    .withColumn(\"diseaseId\", F.col(\"efo_column\"))\n",
    "    .withColumnRenamed(\"target\", \"approvedSymbol\")\n",
    ")\n",
    "### Make chembl T-D-MaxClinPhase pairs and join with approved Symbol\n",
    "chemblTD = (\n",
    "    chembl.groupBy(\"targetId\", \"diseaseId\")\n",
    "    .agg(F.max(F.col(\"clinicalPhase\")).alias(\"maxClinPhase\"))\n",
    "    .join(\n",
    "        target.selectExpr(\"id as targetId\", \"approvedSymbol\"), on=\"targetId\", how=\"left\"\n",
    "    )\n",
    ")\n",
    "#### Join Nelson dataset T-I-MaxClinPhase mapped to EFO with Chembl pairs\n",
    "matches = nelson_efo.join(chemblTD, on=[\"approvedSymbol\", \"diseaseId\"], how=\"outer\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "data": {
      "text/plain": [
       "81365"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 11:>                                                         (0 + 1) / 1]\r"
     ]
    }
   ],
   "source": [
    "chemblTD.count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 11:>                                                         (0 + 1) / 1]\r"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 11:>                                                         (0 + 1) / 1]\r"
     ]
    }
   ],
   "source": [
    "matches.toPandas().to_csv(f\"gs://ot-team/jroldan/analysis/matchesNelsonChembl.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 11:>                                                         (0 + 1) / 1]\r"
     ]
    }
   ],
   "source": [
    "matches.toPandas().to_csv(f\"gs://ot-team/jroldan/analysis/matchesNelsonChembl_all.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+----------+\n",
      "|   differences|sum(count)|\n",
      "+--------------+----------+\n",
      "|         equal|      1835|\n",
      "|Nelson<<Chembl|      1912|\n",
      "|Nelson>>Chembl|       701|\n",
      "+--------------+----------+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 335:>                                                        (0 + 1) / 1]\r"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(\n",
    "    F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()\n",
    ").groupBy(\n",
    "    \"combinedPhase\", \"maxClinPhase\"\n",
    ").count().withColumn(\n",
    "    \"differences\",\n",
    "    F.when(F.col(\"combinedPhase\") == F.col(\"maxClinPhase\"), F.lit(\"equal\"))\n",
    "    .when(F.col(\"combinedPhase\") > F.col(\"maxClinPhase\"), F.lit(\"Nelson>>Chembl\"))\n",
    "    .when(F.col(\"combinedPhase\") < F.col(\"maxClinPhase\"), F.lit(\"Nelson<<Chembl\")),\n",
    ").sort(\n",
    "    F.col(\"differences\").desc()\n",
    ").groupBy(\n",
    "    \"differences\"\n",
    ").agg(\n",
    "    F.sum(F.col(\"count\"))\n",
    ").show(\n",
    "    100\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 335:>                (0 + 1) / 1][Stage 343:>                (0 + 1) / 1]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------+------------+-----+--------------+\n",
      "|combinedPhase|maxClinPhase|count|   differences|\n",
      "+-------------+------------+-----+--------------+\n",
      "|          0.5|         0.5|    5|         equal|\n",
      "|          4.0|         4.0|  505|         equal|\n",
      "|          1.0|         1.0|  224|         equal|\n",
      "|          3.0|         3.0|  188|         equal|\n",
      "|          2.0|         2.0|  913|         equal|\n",
      "|          3.0|         2.0|  145|Nelson>>Chembl|\n",
      "|          4.0|         2.0|   74|Nelson>>Chembl|\n",
      "|          2.0|         0.5|    7|Nelson>>Chembl|\n",
      "|          2.0|         1.0|  320|Nelson>>Chembl|\n",
      "|          4.0|         3.0|  108|Nelson>>Chembl|\n",
      "|          4.0|         1.0|   13|Nelson>>Chembl|\n",
      "|          1.0|         0.5|    1|Nelson>>Chembl|\n",
      "|          3.0|         1.0|   32|Nelson>>Chembl|\n",
      "|          3.0|         0.5|    1|Nelson>>Chembl|\n",
      "|          0.5|         1.0|  164|Nelson<<Chembl|\n",
      "|          0.5|         4.0|  309|Nelson<<Chembl|\n",
      "|          1.0|         3.0|   59|Nelson<<Chembl|\n",
      "|          0.5|         3.0|  136|Nelson<<Chembl|\n",
      "|          2.0|         4.0|  301|Nelson<<Chembl|\n",
      "|          2.0|         3.0|  173|Nelson<<Chembl|\n",
      "|          0.5|         2.0|  257|Nelson<<Chembl|\n",
      "|          3.0|         4.0|  132|Nelson<<Chembl|\n",
      "|          1.0|         4.0|  189|Nelson<<Chembl|\n",
      "|          1.0|         2.0|  192|Nelson<<Chembl|\n",
      "+-------------+------------+-----+--------------+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(\n",
    "    F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()\n",
    ").groupBy(\n",
    "    \"combinedPhase\", \"maxClinPhase\"\n",
    ").count().withColumn(\n",
    "    \"differences\",\n",
    "    F.when(F.col(\"combinedPhase\") == F.col(\"maxClinPhase\"), F.lit(\"equal\"))\n",
    "    .when(F.col(\"combinedPhase\") > F.col(\"maxClinPhase\"), F.lit(\"Nelson>>Chembl\"))\n",
    "    .when(F.col(\"combinedPhase\") < F.col(\"maxClinPhase\"), F.lit(\"Nelson<<Chembl\")),\n",
    ").sort(\n",
    "    F.col(\"differences\").desc()\n",
    ").show(\n",
    "    100\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+---------+------------------+------+---------------------------------+--------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+---------------+------------+----------+--------------+-------------+----------+------------+------+-------------+---------+--------+-----------+----------+-----------+--------+------+-----+---------------+-------------+------------+------------+-----------+----------------+------+-----------+------+-----+----------+--------+------------+-------------+\n",
      "|approvedSymbol|diseaseId|indication_mesh_id|ti_uid|indication_association_similarity|indication_mesh_term|historical_max_phase|active_max_phase|combined_max_phase|succ_p_1|succ_1_2|succ_2_3|succ_3_a|orphan|year_launch|assoc_mesh_id|assoc_mesh_term|assoc_source|assoc_info|original_trait|original_link|assoc_year|pic_qtl_pval|pic_h4|af_gnomad_nfe|l2g_share|l2g_rank|assoc_share|assoc_rank|source_name|abs_beta|abs_or|areas|genetic_insight|target_status|ab_tractable|sm_tractable|rhodop_gpcr|nuclear_receptor|enzyme|ion_channel|kinase|label|efo_column|targetId|maxClinPhase|combinedPhase|\n",
      "+--------------+---------+------------------+------+---------------------------------+--------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+---------------+------------+----------+--------------+-------------+----------+------------+------+-------------+---------+--------+-----------+----------+-----------+--------+------+-----+---------------+-------------+------------+------------+-----------+----------------+------+-----------+------+-----+----------+--------+------------+-------------+\n",
      "+--------------+---------+------------------+------+---------------------------------+--------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+---------------+------------+----------+--------------+-------------+----------+------------+------+-------------+---------+--------+-----------+----------+-----------+--------+------+-----+---------------+-------------+------------+------------+-----------+----------------+------+-----------+------+-----+----------+--------+------------+-------------+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 4.0) & (F.col(\"maxClinPhase\") == 0.5)\n",
    ").show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Stage 435:>                                                        (0 + 1) / 1]\r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+----------------------------------------+-----+\n",
      "|label                                   |count|\n",
      "+----------------------------------------+-----+\n",
      "|immune system disease                   |36   |\n",
      "|neoplasm                                |30   |\n",
      "|cardiovascular disease                  |25   |\n",
      "|diabetes mellitus                       |12   |\n",
      "|obesity                                 |10   |\n",
      "|epilepsy                                |10   |\n",
      "|post-traumatic stress disorder          |8    |\n",
      "|atherosclerosis                         |8    |\n",
      "|inflammatory bowel disease              |5    |\n",
      "|heart failure                           |5    |\n",
      "|mental or behavioural disorder          |5    |\n",
      "|chronic obstructive pulmonary disease   |5    |\n",
      "|myocardial infarction                   |4    |\n",
      "|insomnia                                |4    |\n",
      "|Hepatitis, Alcoholic                    |4    |\n",
      "|atrial fibrillation                     |4    |\n",
      "|blood coagulation disease               |4    |\n",
      "|non-small cell lung carcinoma           |3    |\n",
      "|neuralgia                               |3    |\n",
      "|hypertension                            |3    |\n",
      "|lymphoma                                |3    |\n",
      "|skin disease                            |3    |\n",
      "|opioid dependence                       |3    |\n",
      "|age-related macular degeneration        |3    |\n",
      "|cardiac arrhythmia                      |3    |\n",
      "|systemic scleroderma                    |3    |\n",
      "|attention deficit hyperactivity disorder|3    |\n",
      "|Crohn's disease                         |3    |\n",
      "|drug dependence                         |3    |\n",
      "|male infertility                        |2    |\n",
      "|endometriosis                           |2    |\n",
      "|stroke                                  |2    |\n",
      "|malaria                                 |2    |\n",
      "|rheumatoid arthritis                    |2    |\n",
      "|autism                                  |2    |\n",
      "|actinic keratosis                       |2    |\n",
      "|ankylosing spondylitis                  |2    |\n",
      "|gout                                    |2    |\n",
      "|social anxiety disorder                 |2    |\n",
      "|kidney failure                          |2    |\n",
      "|psoriasis                               |2    |\n",
      "|arthritis                               |2    |\n",
      "|acute coronary syndrome                 |2    |\n",
      "|Sjogren syndrome                        |2    |\n",
      "|complex regional pain syndrome          |2    |\n",
      "|obsessive-compulsive disorder           |2    |\n",
      "|Cutaneous T-cell lymphoma               |2    |\n",
      "|angina pectoris                         |2    |\n",
      "|erectile dysfunction                    |2    |\n",
      "|macular degeneration                    |2    |\n",
      "|anemia (phenotype)                      |2    |\n",
      "|chronic kidney disease                  |2    |\n",
      "|irritable bowel syndrome                |2    |\n",
      "|colorectal neoplasm                     |2    |\n",
      "|diabetic retinopathy                    |1    |\n",
      "|ulcerative colitis                      |1    |\n",
      "|poisoning                               |1    |\n",
      "|colitis                                 |1    |\n",
      "|multiple myeloma                        |1    |\n",
      "|conjunctivitis                          |1    |\n",
      "|retinal detachment                      |1    |\n",
      "|dry eye syndrome                        |1    |\n",
      "|retinopathy                             |1    |\n",
      "|unipolar depression                     |1    |\n",
      "|peripheral nervous system disease       |1    |\n",
      "|partial epilepsy                        |1    |\n",
      "|diabetic nephropathy                    |1    |\n",
      "|idiopathic pulmonary fibrosis           |1    |\n",
      "|polycystic ovary syndrome               |1    |\n",
      "|emphysema                               |1    |\n",
      "|gastric ulcer                           |1    |\n",
      "|gastroesophageal reflux disease         |1    |\n",
      "|bone fracture                           |1    |\n",
      "|juvenile idiopathic arthritis           |1    |\n",
      "|pneumonia                               |1    |\n",
      "|metabolic disease                       |1    |\n",
      "|small cell lung carcinoma               |1    |\n",
      "|diffuse large B-cell lymphoma           |1    |\n",
      "|benign prostatic hyperplasia            |1    |\n",
      "|non-Hodgkins lymphoma                   |1    |\n",
      "|metabolic syndrome                      |1    |\n",
      "|kidney disease                          |1    |\n",
      "|seborrheic dermatitis                   |1    |\n",
      "|endocrine system disease                |1    |\n",
      "|contact dermatitis                      |1    |\n",
      "|lupus nephritis                         |1    |\n",
      "|freckles                                |1    |\n",
      "|brain neoplasm                          |1    |\n",
      "|infection                               |1    |\n",
      "|cardiomyopathy                          |1    |\n",
      "|hepatitis C virus infection             |1    |\n",
      "|non-alcoholic fatty liver disease       |1    |\n",
      "|viral disease                           |1    |\n",
      "|retinal vein occlusion                  |1    |\n",
      "|rhinitis                                |1    |\n",
      "|breast neoplasm                         |1    |\n",
      "|wet macular degeneration                |1    |\n",
      "|female infertility                      |1    |\n",
      "+----------------------------------------+-----+\n",
      "\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 0.5) & (F.col(\"maxClinPhase\") == 4.0)\n",
    ").groupBy(\n",
    "    \"label\"\n",
    ").count().sort(\n",
    "    F.col(\"count\").desc()\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+-----+\n",
      "|approvedSymbol|count|\n",
      "+--------------+-----+\n",
      "|NR3C1         |11   |\n",
      "|PTGS2         |8    |\n",
      "|PTGS1         |6    |\n",
      "|CNR1          |5    |\n",
      "|ESR1          |5    |\n",
      "|PGF           |5    |\n",
      "|ACE           |4    |\n",
      "|GRIN1         |4    |\n",
      "|OPRM1         |4    |\n",
      "|PPARG         |4    |\n",
      "|ADORA2B       |4    |\n",
      "|HMGCR         |4    |\n",
      "|VEGFA         |3    |\n",
      "|ADRA2A        |3    |\n",
      "|OPRD1         |3    |\n",
      "|AGTR1         |3    |\n",
      "|VDR           |3    |\n",
      "|PDE3A         |3    |\n",
      "|ADORA3        |3    |\n",
      "|HRH1          |3    |\n",
      "|TRPV1         |3    |\n",
      "|SLC5A2        |3    |\n",
      "|RXRG          |2    |\n",
      "|GABRA4        |2    |\n",
      "|FKBP1A        |2    |\n",
      "|SLC6A4        |2    |\n",
      "|PGR           |2    |\n",
      "|CRBN          |2    |\n",
      "|SCN5A         |2    |\n",
      "|MT-ND1        |2    |\n",
      "|HTR3A         |2    |\n",
      "|PDE10A        |2    |\n",
      "|ABAT          |2    |\n",
      "|TUBB          |2    |\n",
      "|SCN1A         |2    |\n",
      "|TNF           |2    |\n",
      "|TNFSF13B      |2    |\n",
      "|IFNG          |2    |\n",
      "|PDE4A         |2    |\n",
      "|MS4A1         |2    |\n",
      "|AR            |2    |\n",
      "|ITGB7         |2    |\n",
      "|HTR1F         |2    |\n",
      "|IL17A         |2    |\n",
      "|PDE4D         |2    |\n",
      "|TLR7          |2    |\n",
      "|CHRM3         |2    |\n",
      "|ADA           |2    |\n",
      "|SLC6A2        |2    |\n",
      "|XDH           |2    |\n",
      "|CHRM1         |2    |\n",
      "|C5AR1         |2    |\n",
      "|CACNA1C       |2    |\n",
      "|C5            |2    |\n",
      "|RXRA          |2    |\n",
      "|SCN9A         |2    |\n",
      "|ADORA2A       |2    |\n",
      "|CD2           |2    |\n",
      "|ITGA4         |2    |\n",
      "|RXRB          |2    |\n",
      "|GABRA1        |2    |\n",
      "|S1PR3         |2    |\n",
      "|GABRD         |2    |\n",
      "|TUBB3         |2    |\n",
      "|HTR2C         |2    |\n",
      "|KCNJ8         |1    |\n",
      "|KCNK9         |1    |\n",
      "|C3            |1    |\n",
      "|HTR1A         |1    |\n",
      "|CHRNA4        |1    |\n",
      "|CD86          |1    |\n",
      "|CD3E          |1    |\n",
      "|CCR5          |1    |\n",
      "|DDR2          |1    |\n",
      "|NPM1          |1    |\n",
      "|DRD1          |1    |\n",
      "|IL1B          |1    |\n",
      "|TNFRSF17      |1    |\n",
      "|FSHR          |1    |\n",
      "|PLG           |1    |\n",
      "|GABBR1        |1    |\n",
      "|IFNGR1        |1    |\n",
      "|SSTR2         |1    |\n",
      "|ANGPTL3       |1    |\n",
      "|IL6           |1    |\n",
      "|FGB           |1    |\n",
      "|KIT           |1    |\n",
      "|GLP1R         |1    |\n",
      "|IL23A         |1    |\n",
      "|ATP1A1        |1    |\n",
      "|P4HTM         |1    |\n",
      "|TTR           |1    |\n",
      "|HTR2A         |1    |\n",
      "|ABCC9         |1    |\n",
      "|GABRA3        |1    |\n",
      "|FGA           |1    |\n",
      "|SCN10A        |1    |\n",
      "|IL11RA        |1    |\n",
      "|PPARA         |1    |\n",
      "|F2            |1    |\n",
      "|TYK2          |1    |\n",
      "|LHCGR         |1    |\n",
      "|GIPR          |1    |\n",
      "|PRKCI         |1    |\n",
      "|IL1RAP        |1    |\n",
      "|DRD2          |1    |\n",
      "|PRKD1         |1    |\n",
      "|EDNRA         |1    |\n",
      "|CYP17A1       |1    |\n",
      "|ACHE          |1    |\n",
      "|TNNC1         |1    |\n",
      "|SLC6A1        |1    |\n",
      "|DNMT1         |1    |\n",
      "|PDE8B         |1    |\n",
      "|SLC6A3        |1    |\n",
      "|IFNAR2        |1    |\n",
      "|GAA           |1    |\n",
      "|ACLY          |1    |\n",
      "|KCNQ4         |1    |\n",
      "|JAK1          |1    |\n",
      "|SERPINC1      |1    |\n",
      "|SSTR4         |1    |\n",
      "|PRKCG         |1    |\n",
      "|CACNA1D       |1    |\n",
      "|PDGFRA        |1    |\n",
      "|JAK2          |1    |\n",
      "|ADRB1         |1    |\n",
      "|GART          |1    |\n",
      "|HDAC8         |1    |\n",
      "|MTOR          |1    |\n",
      "|ESR2          |1    |\n",
      "|ELANE         |1    |\n",
      "|ADRA2B        |1    |\n",
      "|GRIN2D        |1    |\n",
      "|ITGA2B        |1    |\n",
      "|SIGMAR1       |1    |\n",
      "|ADRB2         |1    |\n",
      "|PPIA          |1    |\n",
      "|PDE4B         |1    |\n",
      "|EPHA3         |1    |\n",
      "|HTR1B         |1    |\n",
      "|C1S           |1    |\n",
      "|KCNA5         |1    |\n",
      "|OPRK1         |1    |\n",
      "|CA2           |1    |\n",
      "|CALCB         |1    |\n",
      "|PDGFRB        |1    |\n",
      "|TOP2A         |1    |\n",
      "|ADORA1        |1    |\n",
      "|KCNJ11        |1    |\n",
      "|NR1H4         |1    |\n",
      "|GABRA2        |1    |\n",
      "|DHFR          |1    |\n",
      "|NPC1L1        |1    |\n",
      "|IL6R          |1    |\n",
      "|MTNR1B        |1    |\n",
      "|SCN2A         |1    |\n",
      "|MIF           |1    |\n",
      "|TLR9          |1    |\n",
      "|PRKCZ         |1    |\n",
      "|GABRA5        |1    |\n",
      "|PCSK9         |1    |\n",
      "|HTR5A         |1    |\n",
      "|ITGB3         |1    |\n",
      "|SLAMF7        |1    |\n",
      "|ROCK2         |1    |\n",
      "|PTK6          |1    |\n",
      "|SCN3A         |1    |\n",
      "|CALCA         |1    |\n",
      "|NTRK1         |1    |\n",
      "|NPR1          |1    |\n",
      "|PTGIR         |1    |\n",
      "|GRIN2B        |1    |\n",
      "|CD79B         |1    |\n",
      "|OXTR          |1    |\n",
      "|LCK           |1    |\n",
      "|HBB           |1    |\n",
      "|IL12B         |1    |\n",
      "|CHRM2         |1    |\n",
      "|PMEL          |1    |\n",
      "|MAPK11        |1    |\n",
      "|PDE4C         |1    |\n",
      "|KDR           |1    |\n",
      "|FGG           |1    |\n",
      "|EPOR          |1    |\n",
      "|IFNAR1        |1    |\n",
      "|EPHB3         |1    |\n",
      "|MTNR1A        |1    |\n",
      "|EPHA1         |1    |\n",
      "|IL3RA         |1    |\n",
      "|HDAC3         |1    |\n",
      "|SLC10A1       |1    |\n",
      "|JAK3          |1    |\n",
      "|HRH2          |1    |\n",
      "+--------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 0.5) & (F.col(\"maxClinPhase\") == 4.0)\n",
    ").groupBy(\n",
    "    \"approvedSymbol\"\n",
    ").count().sort(\n",
    "    F.col(\"count\").desc()\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+-----------+------------------+---------------+---------------------------------+--------------------------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+-------------------------------------------+------------+--------------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+----------+------------+--------+-------------+---------+--------+-----------+----------+-----------+----------+-----------+------------------------------------------------------+---------------+----------------------------+------------+------------+-----------+----------------+------+-----------+------+-------------------------------------+-----------+---------------+------------+-------------+\n",
      "|approvedSymbol|diseaseId  |indication_mesh_id|ti_uid         |indication_association_similarity|indication_mesh_term                  |historical_max_phase|active_max_phase|combined_max_phase|succ_p_1|succ_1_2|succ_2_3|succ_3_a|orphan|year_launch|assoc_mesh_id|assoc_mesh_term                            |assoc_source|assoc_info                                  |original_trait                                                                                            |original_link                                                                                                                        |assoc_year|pic_qtl_pval|pic_h4  |af_gnomad_nfe|l2g_share|l2g_rank|assoc_share|assoc_rank|source_name|abs_beta  |abs_or     |areas                                                 |genetic_insight|target_status               |ab_tractable|sm_tractable|rhodop_gpcr|nuclear_receptor|enzyme|ion_channel|kinase|label                                |efo_column |targetId       |maxClinPhase|combinedPhase|\n",
      "+--------------+-----------+------------------+---------------+---------------------------------+--------------------------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+-------------------------------------------+------------+--------------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+----------+------------+--------+-------------+---------+--------+-----------+----------+-----------+----------+-----------+------------------------------------------------------+---------------+----------------------------+------------+------------+-----------+----------------+------+-----------+------+-------------------------------------+-----------+---------------+------------+-------------+\n",
      "|FGFR2         |EFO_1001513|D008113           |FGFR2-D008113  |0.671                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Liver enzyme levels (gamma-glutamyl transferase)                                                          |https://genetics.opentargets.org/study/GCST90013407                                                                                  |2021      |null        |null    |0.564816019  |0.92     |1       |0.92       |1         |GWAS       |0.00439844|null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000066468|2.0         |4.0          |\n",
      "|IL6           |EFO_0000685|D001172           |IL6-D001172    |0.413                            |Arthritis, Rheumatoid                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D001249      |Asthma                                     |OTG         |null                                        |Asthma (childhood onset)                                                                                  |https://genetics.opentargets.org/study/GCST007800                                                                                    |2019      |null        |null    |0.29319542   |0.52     |1       |0.52       |1         |GWAS       |null      |null       |musculoskeletal, dermatology, immune                  |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |rheumatoid arthritis                 |EFO_0000685|ENSG00000136244|3.0         |4.0          |\n",
      "|CNR1          |EFO_0003768|D014029           |CNR1-D014029   |0.014                            |Tobacco Use Disorder                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2016       |D000069196   |Gastrointestinal Microbiome                |OTG         |null                                        |Gut microbiota (functional units) [PWY-5345_superpathway_of_L-methionine_biosynthesis_(by_sulfhydrylation]|https://genetics.opentargets.org/study/GCST003854_29                                                                                 |2016      |null        |null    |0.192327665  |0.9      |1       |0.9        |1         |GWAS       |5.4949656 |null       |psychiatry                                            |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |nicotine dependence                  |EFO_0003768|ENSG00000118432|2.0         |4.0          |\n",
      "|CSF1R         |EFO_0002430|D055728           |CSF1R-D055728  |0.476                            |Primary Myelofibrosis                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Granulocyte percentage of myeloid white cells                                                             |https://genetics.opentargets.org/study/GCST004608                                                                                    |2016      |null        |null    |0.633411581  |0.58     |1       |0.58       |1         |GWAS       |0.03435342|null       |hematology                                            |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |primary myelofibrosis                |EFO_0002430|ENSG00000182578|1.0         |4.0          |\n",
      "|FLT4          |EFO_0004230|D016889           |FLT4-D016889   |0.514                            |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000037280|3.0         |4.0          |\n",
      "|FGFR3         |EFO_0003865|D007680           |FGFR3-D007680  |0.874                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001749      |Urinary Bladder Neoplasms                  |PICCOLO     |gtex-v6p-adipose-subcutaneous               |bladder_cancer                                                                                            |https://www.ncbi.nlm.nih.gov/pubmed/20972438                                                                                         |2010      |6.04E-15    |0.912895|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |both           |genetically supported target|TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000068078|2.0         |4.0          |\n",
      "|CD276         |EFO_0000621|D009447           |CD276-D009447  |0.231                            |Neuroblastoma                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Sex hormone-binding globulin levels adjusted for BMI                                                      |https://genetics.opentargets.org/study/GCST90012108                                                                                  |2020      |null        |null    |0.398595944  |0.8      |1       |0.8        |1         |GWAS       |0.00660829|null       |oncology                                              |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |neuroblastoma                        |EFO_0000621|ENSG00000103855|2.0         |4.0          |\n",
      "|AR            |EFO_0000284|D011470           |AR-D011470     |0.372                            |Prostatic Hyperplasia                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011471      |Prostatic Neoplasms                        |OTG         |null                                        |Malignant neoplasm of prostate                                                                            |https://genetics.opentargets.org/study/FINNGEN_R6_C3_PROSTATE                                                                        |2022      |null        |null    |0.001936733  |0.77     |1       |0.77       |1         |GWAS       |null      |1.33530536 |other                                                 |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |benign prostatic hyperplasia         |EFO_0000284|ENSG00000169083|2.0         |4.0          |\n",
      "|FGFR4         |EFO_0003060|D002289           |FGFR4-D002289  |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.307667316  |0.69     |1       |0.69       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000160867|3.0         |4.0          |\n",
      "|ERBB4         |EFO_0003869|D001943           |ERBB4-D001943  |1                                |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D001943      |Breast Neoplasms                           |OTG         |null                                        |Breast cancer                                                                                             |https://genetics.opentargets.org/study/GCST001457                                                                                    |2012      |null        |null    |0.088945115  |1        |1       |1          |1         |GWAS       |null      |1.53       |oncology                                              |both           |genetically supported target|TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |breast neoplasm                      |EFO_0003869|ENSG00000178568|3.0         |4.0          |\n",
      "|CD19          |EFO_0005952|D008228           |CD19-D008228   |0.365                            |Lymphoma, Non-Hodgkin                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D017074      |Common Variable Immunodeficiency           |OMIM        |null                                        |Immunodeficiency, common variable, 3, 613493 (3), Autosomal recessive                                     |https://omim.org/entry/107265                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-Hodgkins lymphoma                |EFO_0005952|ENSG00000177455|3.0         |4.0          |\n",
      "|FGFR2         |EFO_0003060|D002289           |FGFR2-D002289  |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2018       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.566796621  |0.81     |1       |0.81       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000066468|3.0         |4.0          |\n",
      "|FGFR1         |EFO_1001513|D008113           |FGFR1-D008113  |0.671                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Liver enzyme levels (alanine transaminase)                                                                |https://genetics.opentargets.org/study/GCST90013405                                                                                  |2021      |null        |null    |0.413416537  |0.81     |1       |0.81       |1         |GWAS       |0.00219045|null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000077782|2.0         |4.0          |\n",
      "|CYP11B2       |EFO_1001110|D047748           |CYP11B2-D047748|0.453                            |Pituitary ACTH Hypersecretion         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006994      |Hypoaldosteronism                          |OMIM        |null                                        |Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3), Autosomal recessive                   |https://omim.org/entry/124080                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |neurology, endocrine                                  |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |pituitary-dependent Cushing's disease|EFO_1001110|ENSG00000179142|3.0         |4.0          |\n",
      "|BTK           |EFO_0005952|D008228           |BTK-D008228    |0.261                            |Lymphoma, Non-Hodgkin                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D040181      |Genetic Diseases, X-Linked                 |OMIM        |null                                        |Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive                                            |https://omim.org/entry/300300                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-Hodgkins lymphoma                |EFO_0005952|ENSG00000010671|3.0         |4.0          |\n",
      "|FKBP1A        |EFO_1000906|D015352           |FKBP1A-D015352 |0.03                             |Dry Eye Syndromes                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D005919      |Glomerular Filtration Rate                 |OTG         |null                                        |Estimated glomerular filtration rate in non-diabetics                                                     |https://genetics.opentargets.org/study/GCST008745                                                                                    |2019      |null        |null    |0.067878001  |0.52     |1       |0.52       |1         |GWAS       |0.605     |null       |ophthalmology                                         |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |dry eye syndrome                     |EFO_1000906|ENSG00000088832|2.0         |4.0          |\n",
      "|FGFR3         |EFO_0009001|D008415           |FGFR3-D008415  |0.491                            |Mastocytosis                          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D000505      |Alopecia                                   |OTG         |null                                        |Male-pattern baldness                                                                                     |https://genetics.opentargets.org/study/GCST007020                                                                                    |2018      |null        |null    |0.296383034  |0.66     |1       |0.66       |1         |GWAS       |0.0201814 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |Mastocytosis                         |EFO_0009001|ENSG00000068078|2.0         |4.0          |\n",
      "|FGFR1         |EFO_0003860|D010190           |FGFR1-D010190  |0.599                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.409385756  |0.83     |1       |0.83       |1         |GWAS       |0.0201248 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |pancreatic neoplasm                  |EFO_0003860|ENSG00000077782|2.0         |4.0          |\n",
      "|FLT1          |EFO_0003865|D007680           |FLT1-D007680   |0.511                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011225      |Pre-Eclampsia                              |OTG         |null                                        |Preeclampsia (fetal genotype effect)                                                                      |https://genetics.opentargets.org/study/GCST90013475                                                                                  |2020      |null        |null    |0.498830257  |0.62     |1       |0.62       |1         |GWAS       |null      |1.19       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000102755|3.0         |4.0          |\n",
      "|CD274         |EFO_0000183|D006689           |CD274-D006689  |0.203                            |Hodgkin Disease                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism                                                                                            |https://genetics.opentargets.org/study/GCST007073                                                                                    |2018      |null        |null    |0.156136482  |0.67     |1       |0.67       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Hodgkins lymphoma                    |EFO_0000183|ENSG00000120217|2.0         |4.0          |\n",
      "|LYN           |EFO_0000768|D054990           |LYN-D054990    |0.229                            |Idiopathic Pulmonary Fibrosis         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2015       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Sum neutrophil eosinophil counts                                                                          |https://genetics.opentargets.org/study/GCST004613                                                                                    |2016      |null        |null    |0.68223205   |0.85     |1       |0.85       |1         |GWAS       |0.02448989|null       |respiratory                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |idiopathic pulmonary fibrosis        |EFO_0000768|ENSG00000254087|1.0         |4.0          |\n",
      "|PDCD1         |EFO_0004252|D009303           |PDCD1-D009303  |0                                |Nasopharyngeal Neoplasms              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |nasopharyngeal neoplasm              |EFO_0004252|ENSG00000188389|3.0         |4.0          |\n",
      "|PLAT          |EFO_0000319|D002318           |PLAT-D002318   |0.243                            |Cardiovascular Diseases               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D017496      |Hypopigmentation                           |OTG         |null                                        |Skin colour                                                                                               |https://genetics.opentargets.org/study/NEALE2_1717                                                                                   |2018      |null        |null    |0.572023422  |0.5      |1       |0.5        |1         |GWAS       |0.00777909|null       |cardiovascular                                        |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |cardiovascular disease               |EFO_0000319|ENSG00000104368|3.0         |4.0          |\n",
      "|BRAF          |EFO_0003060|D002289           |BRAF-D002289   |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FVC)                                                                                       |https://genetics.opentargets.org/study/GCST007081                                                                                    |2018      |null        |null    |0.536907083  |0.78     |1       |0.78       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000157764|3.0         |4.0          |\n",
      "|APOC3         |EFO_1000727|D008060           |APOC3-D008060  |0.733                            |Lipodystrophy                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006937      |Hypercholesterolemia                       |OTG         |null                                        |Total cholesterol levels                                                                                  |https://genetics.opentargets.org/study/GCST90025953                                                                                  |2021      |null        |null    |0.612917913  |0.66     |1       |0.66       |1         |GWAS       |0.0334341 |null       |dermatology, metabolic                                |omim/tcga      |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |lipodystrophy                        |EFO_1000727|ENSG00000110245|2.0         |4.0          |\n",
      "|FGFR3         |EFO_0000702|D055752           |FGFR3-D055752  |0.759                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.066878568  |0.8      |1       |0.8        |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |small cell lung carcinoma            |EFO_0000702|ENSG00000068078|2.0         |4.0          |\n",
      "|FLT1          |EFO_0003060|D002289           |FLT1-D002289   |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.921475814  |0.89     |1       |0.89       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000102755|3.0         |4.0          |\n",
      "|IL4R          |EFO_0007486|D012852           |IL4R-D012852   |0.612                            |Sinusitis                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D012140      |Respiratory Tract Diseases                 |OTG         |null                                        |Chronic lower respiratory diseases                                                                        |https://genetics.opentargets.org/study/FINNGEN_R6_J10_LOWCHRON                                                                       |2022      |null        |null    |0.007192846  |0.81     |1       |0.81       |1         |GWAS       |null      |1.11478326 |infection, respiratory                                |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |sinusitis                            |EFO_0007486|ENSG00000077238|3.0         |4.0          |\n",
      "|SCN5A         |EFO_0004287|D014693           |SCN5A-D014693  |1                                |Ventricular Fibrillation              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2009       |D014693      |Ventricular Fibrillation                   |OMIM        |null                                        |Ventricular fibrillation, familial, 1, 603829 (3)                                                         |https://omim.org/entry/600163                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |cardiovascular, signs/symptoms                        |omim/tcga      |genetically supported target|TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |ventricular fibrillation             |EFO_0004287|ENSG00000183873|3.0         |4.0          |\n",
      "|IL17F         |EFO_0003898|D013167           |IL17F-D013167  |0.198                            |Spondylitis, Ankylosing               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001791      |Blood Platelet Disorders                   |OTG         |null                                        |Mean platelet volume                                                                                      |https://genetics.opentargets.org/study/GCST004599                                                                                    |2016      |null        |null    |0.062294651  |0.58     |1       |0.58       |1         |GWAS       |0.04578266|null       |musculoskeletal                                       |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ankylosing spondylitis               |EFO_0003898|ENSG00000112116|3.0         |4.0          |\n",
      "|VEGFA         |EFO_0003865|D007680           |VEGFA-D007680  |0.79                             |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011471      |Prostatic Neoplasms                        |OTG         |null                                        |Prostate cancer                                                                                           |https://genetics.opentargets.org/study/GCST011049                                                                                    |2021      |null        |null    |0.501558644  |0.7      |1       |0.7        |1         |GWAS       |null      |1.039      |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000112715|2.0         |4.0          |\n",
      "|MAP2K1        |EFO_0004142|D015179           |MAP2K1-D015179 |0.455                            |Colorectal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D009373      |Neoplasms, Germ Cell and Embryonal         |PICCOLO     |CD4-meta-cis                                |testicular_germ_cell_tumor                                                                                |https://www.ncbi.nlm.nih.gov/pubmed/28604728                                                                                         |2017      |2.72E-20    |0.907482|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |colorectal neoplasm                  |EFO_0004142|ENSG00000169032|2.0         |4.0          |\n",
      "|VEGFA         |EFO_0002939|D008527           |VEGFA-D008527  |0.39                             |Medulloblastoma                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011471      |Prostatic Neoplasms                        |OTG         |null                                        |Prostate cancer                                                                                           |https://genetics.opentargets.org/study/GCST011049                                                                                    |2021      |null        |null    |0.501558644  |0.7      |1       |0.7        |1         |GWAS       |null      |1.039      |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |medulloblastoma                      |EFO_0002939|ENSG00000112715|2.0         |4.0          |\n",
      "|TOP2A         |EFO_0000621|D009447           |TOP2A-D009447  |0                                |Neuroblastoma                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |neuroblastoma                        |EFO_0000621|ENSG00000131747|3.0         |4.0          |\n",
      "|NR1H4         |EFO_0003095|D065626           |NR1H4-D065626  |0.601                            |Non-alcoholic Fatty Liver Disease     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Liver enzyme levels (gamma-glutamyl transferase)                                                          |https://genetics.opentargets.org/study/GCST90013407                                                                                  |2021      |null        |null    |0.064954486  |0.85     |1       |0.85       |1         |GWAS       |0.00768656|null       |digestive                                             |both           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |non-alcoholic fatty liver disease    |EFO_0003095|ENSG00000012504|3.0         |4.0          |\n",
      "|KIT           |EFO_0003893|D010051           |KIT-D010051    |0.528                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |ovarian neoplasm                     |EFO_0003893|ENSG00000157404|2.0         |4.0          |\n",
      "|IL17RA        |EFO_0003778|D015535           |IL17RA-D015535 |0.409                            |Arthritis, Psoriatic                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2016       |D002178      |Candidiasis, Chronic Mucocutaneous         |OMIM        |null                                        |Immunodeficiency 51, 613953 (3), Autosomal recessive                                                      |https://omim.org/entry/605461                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |musculoskeletal, dermatology                          |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |psoriatic arthritis                  |EFO_0003778|ENSG00000177663|3.0         |4.0          |\n",
      "|FGFR3         |EFO_0003893|D010051           |FGFR3-D010051  |0.769                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001749      |Urinary Bladder Neoplasms                  |PICCOLO     |gtex-v6p-adipose-subcutaneous               |bladder_cancer                                                                                            |https://www.ncbi.nlm.nih.gov/pubmed/20972438                                                                                         |2010      |6.04E-15    |0.912895|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |ovarian neoplasm                     |EFO_0003893|ENSG00000068078|2.0         |4.0          |\n",
      "|GNRHR         |EFO_0003869|D001943           |GNRHR-D001943  |0.2                              |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007006      |Hypogonadism                               |OMIM        |null                                        |Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3), Autosomal recessive                          |https://omim.org/entry/138850                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000109163|3.0         |4.0          |\n",
      "|SCN1A         |EFO_0008526|D013226           |SCN1A-D013226  |0.758                            |Status Epilepticus                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D003294      |Seizures, Febrile                          |OTG         |null                                        |Febrile seizures [Overall]                                                                                |https://genetics.opentargets.org/study/GCST002672_2                                                                                  |2014      |null        |null    |0.68772846   |0.71     |1       |0.71       |1         |GWAS       |null      |1.34       |neurology, signs/symptoms                             |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |status epilepticus                   |EFO_0008526|ENSG00000144285|3.0         |4.0          |\n",
      "|RET           |EFO_0002429|D011087           |RET-D011087    |0.548                            |Polycythemia Vera                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D013964      |Thyroid Neoplasms                          |OMIM        |null                                        |Medullary thyroid carcinoma, 155240 (3), Autosomal dominant                                               |https://omim.org/entry/164761                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |polycythemia vera                    |EFO_0002429|ENSG00000165731|2.0         |4.0          |\n",
      "|TOP2A         |EFO_0000095|D015451           |TOP2A-D015451  |0                                |Leukemia, Lymphocytic, Chronic, B-Cell|Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |chronic lymphocytic leukemia         |EFO_0000095|ENSG00000131747|3.0         |4.0          |\n",
      "|TYMS          |EFO_0003860|D010190           |TYMS-D010190   |0.599                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Sex hormone-binding globulin levels                                                                       |https://genetics.opentargets.org/study/GCST90012109                                                                                  |2020      |null        |null    |0.265145606  |0.64     |1       |0.64       |1         |GWAS       |0.00815923|null       |oncology                                              |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000176890|3.0         |4.0          |\n",
      "|IL2RA         |EFO_0000699|D012859           |IL2RA-D012859  |0.803                            |Sjogren's Syndrome                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001172      |Arthritis, Rheumatoid                      |OTG         |null                                        |Rheumatoid arthritis                                                                                      |https://genetics.opentargets.org/study/GCST002318                                                                                    |2013      |null        |null    |0.423422836  |0.85     |1       |0.85       |1         |GWAS       |null      |1.1        |musculoskeletal, ophthalmology, dermatology, immune   |both           |genetically supported target|TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Sjogren syndrome                     |EFO_0000699|ENSG00000134460|1.0         |4.0          |\n",
      "|OPRD1         |EFO_0000555|D043183           |OPRD1-D043183  |0.498                            |Irritable Bowel Syndrome              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D005764      |Gastroesophageal Reflux                    |OTG         |null                                        |Gastroesophageal reflux disease                                                                           |https://genetics.opentargets.org/study/GCST90000514                                                                                  |2021      |null        |null    |0.12665886   |0.83     |1       |0.83       |1         |GWAS       |null      |1.038647111|digestive                                             |gwas           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |irritable bowel syndrome             |EFO_0000555|ENSG00000116329|2.0         |4.0          |\n",
      "|FGFR4         |EFO_0000222|D015470           |FGFR4-D015470  |0.215                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D003924      |Diabetes Mellitus, Type 2                  |OTG         |null                                        |Type 2 diabetes                                                                                           |https://genetics.opentargets.org/study/GCST007847                                                                                    |2019      |null        |null    |0.287970141  |0.69     |1       |0.69       |1         |GWAS       |null      |1.06       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000160867|2.0         |4.0          |\n",
      "|CSF3R         |EFO_0004272|D000740           |CSF3R-D000740  |0.577                            |Anemia                                |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |Genebass    |missenseLC skat continuous both_sexes irnt  |Monocyte percentage                                                                                       |https://genebass.org/gene/ENSG00000119535/phenotype/continuous-30190-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.00095435|null       |hematology                                            |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |anemia (phenotype)                   |EFO_0004272|ENSG00000119535|3.0         |4.0          |\n",
      "|ABCB1         |EFO_0000565|D007938           |ABCB1-D007938  |0.037                            |Leukemia                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D049628      |Body Size                                  |OTG         |null                                        |Appendicular lean mass                                                                                    |https://genetics.opentargets.org/study/GCST90000025                                                                                  |2020      |null        |null    |0.180548337  |0.71     |1       |0.71       |1         |GWAS       |0.0158    |null       |oncology                                              |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |leukemia                             |EFO_0000565|ENSG00000085563|3.0         |4.0          |\n",
      "|IL17F         |EFO_0003778|D015535           |IL17F-D015535  |0.194                            |Arthritis, Psoriatic                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001791      |Blood Platelet Disorders                   |OTG         |null                                        |Mean platelet volume                                                                                      |https://genetics.opentargets.org/study/GCST004599                                                                                    |2016      |null        |null    |0.062294651  |0.58     |1       |0.58       |1         |GWAS       |0.04578266|null       |musculoskeletal, dermatology                          |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |psoriatic arthritis                  |EFO_0003778|ENSG00000112116|3.0         |4.0          |\n",
      "|SCN2A         |EFO_0008526|D013226           |SCN2A-D013226  |0.758                            |Status Epilepticus                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D003294      |Seizures, Febrile                          |OTG         |null                                        |Febrile seizures [Overall]                                                                                |https://genetics.opentargets.org/study/GCST002672_2                                                                                  |2014      |null        |null    |0.405801868  |0.76     |1       |0.76       |1         |GWAS       |null      |1.22       |neurology, signs/symptoms                             |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |status epilepticus                   |EFO_0008526|ENSG00000136531|3.0         |4.0          |\n",
      "|TNF           |EFO_0003780|D001528           |TNF-D001528    |0.034                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D015415      |Biomarkers                                 |OTG         |null                                        |Blood protein levels [MICB, 5102_55_3]                                                                    |https://genetics.opentargets.org/study/GCST006585_1148                                                                               |2018      |null        |null    |0.070093458  |0.51     |1       |0.51       |1         |GWAS       |0.9721669 |null       |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000232810|3.0         |4.0          |\n",
      "|KDR           |EFO_0003893|D010051           |KDR-D010051    |0.554                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004715      |Endometriosis                              |OTG         |null                                        |Endometriosis                                                                                             |https://genetics.opentargets.org/study/FINNGEN_R6_N14_ENDOMETRIOSIS                                                                  |2022      |null        |null    |0.283441982  |0.9      |1       |0.9        |1         |GWAS       |null      |1.150273799|oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000128052|2.0         |4.0          |\n",
      "|SCN3A         |EFO_0008526|D013226           |SCN3A-D013226  |0.386                            |Status Epilepticus                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004827      |Epilepsy                                   |OMIM        |null                                        |Epilepsy, familial focal, with variable foci 4, 617935 (3), Autosomal dominant                            |https://omim.org/entry/182391                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |neurology, signs/symptoms                             |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |status epilepticus                   |EFO_0008526|ENSG00000153253|3.0         |4.0          |\n",
      "|PDCD1         |EFO_0004230|D016889           |PDCD1-D016889  |0                                |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000188389|3.0         |4.0          |\n",
      "|KDR           |EFO_1001513|D008113           |KDR-D008113    |0.246                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2019       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Hemoglobin levels                                                                                         |https://genetics.opentargets.org/study/GCST90025969                                                                                  |2021      |null        |null    |0.03772851   |0.62     |1       |0.62       |1         |GWAS       |0.0303592 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000128052|2.0         |4.0          |\n",
      "|TGFB1         |EFO_0000768|D054990           |TGFB1-D054990  |0.235                            |Idiopathic Pulmonary Fibrosis         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2014       |D010003      |Osteoarthritis                             |OTG         |null                                        |Osteoarthritis                                                                                            |https://genetics.opentargets.org/study/GCST90038686                                                                                  |2021      |null        |null    |0.029411765  |0.66     |1       |0.66       |1         |GWAS       |null      |1.012771366|respiratory                                           |both           |unsupported target          |FALSE       |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |idiopathic pulmonary fibrosis        |EFO_0000768|ENSG00000105329|1.0         |4.0          |\n",
      "|VEGFA         |EFO_0003833|D001932           |VEGFA-D001932  |0.566                            |Brain Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011471      |Prostatic Neoplasms                        |OTG         |null                                        |Prostate cancer                                                                                           |https://genetics.opentargets.org/study/GCST011049                                                                                    |2021      |null        |null    |0.501558644  |0.7      |1       |0.7        |1         |GWAS       |null      |1.039      |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |brain neoplasm                       |EFO_0003833|ENSG00000112715|2.0         |4.0          |\n",
      "|FGFR3         |EFO_0003060|D002289           |FGFR3-D002289  |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.066878568  |0.8      |1       |0.8        |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000068078|3.0         |4.0          |\n",
      "|JAK3          |EFO_0002609|D001171           |JAK3-D001171   |0.177                            |Arthritis, Juvenile                   |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D053632      |X-Linked Combined Immunodeficiency Diseases|OMIM        |null                                        |SCID, autosomal recessive, T-negative/B-positive type, 600802 (3), Autosomal recessive                    |https://omim.org/entry/600173                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |musculoskeletal, dermatology, immune                  |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |juvenile idiopathic arthritis        |EFO_0002609|ENSG00000105639|3.0         |4.0          |\n",
      "|IL17RA        |EFO_0003898|D013167           |IL17RA-D013167 |0.356                            |Spondylitis, Ankylosing               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D002178      |Candidiasis, Chronic Mucocutaneous         |OMIM        |null                                        |Immunodeficiency 51, 613953 (3), Autosomal recessive                                                      |https://omim.org/entry/605461                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |musculoskeletal                                       |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ankylosing spondylitis               |EFO_0003898|ENSG00000177663|3.0         |4.0          |\n",
      "|KIT           |EFO_1001513|D008113           |KIT-D008113    |0.723                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000157404|2.0         |4.0          |\n",
      "|PLG           |EFO_0000612|D009203           |PLG-D009203    |1                                |Myocardial Infarction                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2003       |D009203      |Myocardial Infarction                      |OTG         |null                                        |Myocardial infarction                                                                                     |https://genetics.opentargets.org/study/GCST003117                                                                                    |2015      |null        |null    |0.09060838   |0.81     |1       |0.81       |1         |GWAS       |null      |1.3        |cardiovascular, signs/symptoms                        |gwas           |genetically supported target|TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |myocardial infarction                |EFO_0000612|ENSG00000122194|3.0         |4.0          |\n",
      "|TOP2A         |EFO_0004230|D016889           |TOP2A-D016889  |0                                |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000131747|3.0         |4.0          |\n",
      "|IFNG          |EFO_0000685|D001172           |IFNG-D001172   |0.349                            |Arthritis, Rheumatoid                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011565      |Psoriasis                                  |OTG         |null                                        |Psoriasis                                                                                                 |https://genetics.opentargets.org/study/GCST005527                                                                                    |2012      |null        |null    |0.025463263  |0.79     |1       |0.79       |1         |GWAS       |null      |11.26126126|musculoskeletal, dermatology, immune                  |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |rheumatoid arthritis                 |EFO_0000685|ENSG00000111537|2.0         |4.0          |\n",
      "|FLT3          |EFO_1001513|D008113           |FLT3-D008113   |0.246                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D006402      |Hematologic Diseases                       |Genebass    |missenseLC burden continuous both_sexes irnt|Monocyte percentage                                                                                       |https://genebass.org/gene/ENSG00000122025/phenotype/continuous-30190-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.0048778 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000122025|2.0         |4.0          |\n",
      "|PDGFRA        |EFO_0003060|D002289           |PDGFRA-D002289 |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007431                                                                                    |2019      |null        |null    |0.200961289  |0.77     |1       |0.77       |1         |GWAS       |0.0173    |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000134853|3.0         |4.0          |\n",
      "|BRAF          |EFO_0003841|D013964           |BRAF-D013964   |0.552                            |Thyroid Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D003924      |Diabetes Mellitus, Type 2                  |OTG         |null                                        |Type 2 diabetes                                                                                           |https://genetics.opentargets.org/study/GCST004894                                                                                    |2017      |null        |null    |0.140890793  |0.77     |1       |0.77       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |thyroid neoplasm                     |EFO_0003841|ENSG00000157764|3.0         |4.0          |\n",
      "|FLT4          |EFO_0003860|D010190           |FLT4-D010190   |0.528                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000037280|2.0         |4.0          |\n",
      "|KDR           |EFO_0003860|D010190           |KDR-D010190    |0.24                             |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Hemoglobin levels                                                                                         |https://genetics.opentargets.org/study/GCST90025969                                                                                  |2021      |null        |null    |0.03772851   |0.62     |1       |0.62       |1         |GWAS       |0.0303592 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000128052|2.0         |4.0          |\n",
      "|IFNAR1        |EFO_0000544|D007239           |IFNAR1-D007239 |0.225                            |Infections                            |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |1989       |D009290      |Narcolepsy                                 |PICCOLO     |Dendritic-cells-Flu                         |narcolepsy                                                                                                |https://www.ncbi.nlm.nih.gov/pubmed/24204295                                                                                         |2013      |2.61E-16    |0.970069|null         |null     |null    |null       |null      |GWAS       |null      |null       |infection                                             |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |infection                            |EFO_0000544|ENSG00000142166|3.0         |4.0          |\n",
      "|SLC5A2        |EFO_0000401|D003928           |SLC5A2-D003928 |0.639                            |Diabetic Nephropathies                |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D006030      |Glycosuria, Renal                          |OMIM        |null                                        |Renal glucosuria, 233100 (3), Autosomal dominant, Autosomal recessive                                     |https://omim.org/entry/182381                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |endocrine                                             |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |diabetic nephropathy                 |EFO_0000401|ENSG00000140675|3.0         |4.0          |\n",
      "|ABCB1         |EFO_0003060|D002289           |ABCB1-D002289  |0.033                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D049628      |Body Size                                  |OTG         |null                                        |Appendicular lean mass                                                                                    |https://genetics.opentargets.org/study/GCST90000025                                                                                  |2020      |null        |null    |0.180548337  |0.71     |1       |0.71       |1         |GWAS       |0.0158    |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000085563|3.0         |4.0          |\n",
      "|CHRM1         |EFO_1000781|D053201           |CHRM1-D053201  |0.391                            |Urinary Bladder, Overactive           |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2012       |D007319      |Sleep Initiation and Maintenance Disorders |OTG         |null                                        |Insomnia [Female]                                                                                         |https://genetics.opentargets.org/study/GCST007988_2                                                                                  |2019      |null        |null    |0.707829367  |0.51     |1       |0.51       |1         |GWAS       |null      |1.051      |signs/symptoms                                        |gwas           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |overactive bladder                   |EFO_1000781|ENSG00000168539|2.0         |4.0          |\n",
      "|IL2RA         |EFO_0000756|D008545           |IL2RA-D008545  |0.254                            |Melanoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Lymphocyte percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004632                                                                                    |2016      |null        |null    |0.079350649  |0.75     |1       |0.75       |1         |GWAS       |0.03780895|null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |melanoma                             |EFO_0000756|ENSG00000134460|3.0         |4.0          |\n",
      "|BTK           |EFO_0000574|D008223           |BTK-D008223    |0.271                            |Lymphoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D040181      |Genetic Diseases, X-Linked                 |OMIM        |null                                        |Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive                                            |https://omim.org/entry/300300                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |lymphoma                             |EFO_0000574|ENSG00000010671|3.0         |4.0          |\n",
      "|TOP2A         |EFO_0003897|D013274           |TOP2A-D013274  |0                                |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |stomach neoplasm                     |EFO_0003897|ENSG00000131747|3.0         |4.0          |\n",
      "|RAF1          |EFO_1001513|D008113           |RAF1-D008113   |0.235                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.356567284  |0.57     |1       |0.57       |1         |GWAS       |0.0206815 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000132155|2.0         |4.0          |\n",
      "|PPARG         |EFO_0001073|D009765           |PPARG-D009765  |1                                |Obesity                               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009765      |Obesity                                    |Genebass    |missenseLC burden continuous both_sexes irnt|Trunk fat mass                                                                                            |https://genebass.org/gene/ENSG00000132170/phenotype/continuous-23128-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.0060003 |null       |metabolic, signs/symptoms                             |both           |genetically supported target|FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |obesity                              |EFO_0001073|ENSG00000132170|2.0         |4.0          |\n",
      "|ADRB1         |EFO_0004287|D014693           |ADRB1-D014693  |0.758                            |Ventricular Fibrillation              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2015       |D001145      |Arrhythmias, Cardiac                       |OTG         |null                                        |PR interval                                                                                               |https://genetics.opentargets.org/study/GCST010320                                                                                    |2020      |null        |null    |0.100831061  |0.78     |1       |0.78       |1         |GWAS       |0.6188    |null       |cardiovascular, signs/symptoms                        |omim/tcga      |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |ventricular fibrillation             |EFO_0004287|ENSG00000043591|3.0         |4.0          |\n",
      "|NR3C1         |EFO_1001110|D047748           |NR3C1-D047748  |0.553                            |Pituitary ACTH Hypersecretion         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2022       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Sex hormone-binding globulin levels adjusted for BMI                                                      |https://genetics.opentargets.org/study/GCST90012110                                                                                  |2020      |null        |null    |0.224565274  |0.9      |1       |0.9        |1         |GWAS       |0.00565119|null       |neurology, endocrine                                  |omim/tcga      |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |pituitary-dependent Cushing's disease|EFO_1001110|ENSG00000113580|3.0         |4.0          |\n",
      "|BCL2          |EFO_0000222|D015470           |BCL2-D015470   |0.697                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2018       |D015451      |Leukemia, Lymphocytic, Chronic, B-Cell     |OTG         |null                                        |Chronic lymphocytic leukemia                                                                              |https://genetics.opentargets.org/study/GCST002073                                                                                    |2013      |null        |null    |0.085690192  |0.82     |1       |0.82       |1         |GWAS       |null      |1.47       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000171791|3.0         |4.0          |\n",
      "|EGFR          |EFO_0003897|D013274           |EGFR-D013274   |0.45                             |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D006484      |Hemorrhoids                                |OTG         |null                                        |Haemorrhoidal disease                                                                                     |https://genetics.opentargets.org/study/GCST90014033                                                                                  |2021      |null        |null    |0.384800104  |0.91     |1       |0.91       |1         |GWAS       |null      |1.029836447|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |stomach neoplasm                     |EFO_0003897|ENSG00000146648|2.0         |4.0          |\n",
      "|BRAF          |EFO_1001513|D008113           |BRAF-D008113   |0.236                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004476      |Ectodermal Dysplasia                       |OMIM        |null                                        |Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant                                             |https://omim.org/entry/164757                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000157764|2.0         |4.0          |\n",
      "|PIK3CD        |EFO_0001378|D009101           |PIK3CD-D009101 |0.714                            |Multiple Myeloma                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008232      |Lymphoproliferative Disorders              |OTG         |null                                        |Monocyte count                                                                                            |https://genetics.opentargets.org/study/GCST90002340                                                                                  |2020      |null        |null    |0.418109621  |0.82     |1       |0.82       |1         |GWAS       |0.022592  |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |multiple myeloma                     |EFO_0001378|ENSG00000171608|2.0         |4.0          |\n",
      "|FGFR2         |EFO_0000222|D015470           |FGFR2-D015470  |0.493                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009369      |Neoplasms                                  |OTG         |null                                        |Malignant neoplasm                                                                                        |https://genetics.opentargets.org/study/FINNGEN_R6_C3_CANCER                                                                          |2022      |null        |null    |0.392197659  |0.92     |1       |0.92       |1         |GWAS       |null      |1.052428131|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000066468|2.0         |4.0          |\n",
      "|PDGFRB        |EFO_0003865|D007680           |PDGFRB-D007680 |0.37                             |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D018224      |Myofibromatosis                            |OMIM        |null                                        |Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant                                             |https://omim.org/entry/173410                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000113721|3.0         |4.0          |\n",
      "|BTK           |EFO_0003060|D002289           |BTK-D002289    |0.232                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D040181      |Genetic Diseases, X-Linked                 |OMIM        |null                                        |Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive                                            |https://omim.org/entry/300300                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000010671|3.0         |4.0          |\n",
      "|IL4R          |EFO_1000391|D009298           |IL4R-D009298   |0.585                            |Nasal Polyps                          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2019       |D012140      |Respiratory Tract Diseases                 |OTG         |null                                        |Chronic lower respiratory diseases                                                                        |https://genetics.opentargets.org/study/FINNGEN_R6_J10_LOWCHRON                                                                       |2022      |null        |null    |0.007192846  |0.81     |1       |0.81       |1         |GWAS       |null      |1.11478326 |respiratory, signs/symptoms                           |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Nasal Cavity Polyp                   |EFO_1000391|ENSG00000077238|2.0         |4.0          |\n",
      "|PDE4C         |EFO_0003780|D001528           |PDE4C-D001528  |0.224                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Gamma glutamyl transferase levels                                                                         |https://genetics.opentargets.org/study/GCST90019507                                                                                  |2021      |null        |null    |0.279063685  |0.54     |1       |0.54       |1         |GWAS       |0.0275    |null       |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000105650|3.0         |4.0          |\n",
      "|TOP1          |EFO_0003897|D013274           |TOP1-D013274   |0.497                            |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Gamma glutamyl transferase levels                                                                         |https://genetics.opentargets.org/study/GCST90025966                                                                                  |2021      |null        |null    |0.479155844  |0.65     |1       |0.65       |1         |GWAS       |0.0324091 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |stomach neoplasm                     |EFO_0003897|ENSG00000198900|3.0         |4.0          |\n",
      "|BTK           |EFO_0000403|D016403           |BTK-D016403    |0.224                            |Lymphoma, Large B-Cell, Diffuse       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D040181      |Genetic Diseases, X-Linked                 |OMIM        |null                                        |Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessive                                            |https://omim.org/entry/300300                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |diffuse large B-cell lymphoma        |EFO_0000403|ENSG00000010671|3.0         |4.0          |\n",
      "|FLT1          |EFO_0003860|D010190           |FLT1-D010190   |0.24                             |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Monocyte percentage of white cells                                                                        |https://genetics.opentargets.org/study/GCST90002394                                                                                  |2020      |null        |null    |0.016874351  |0.77     |1       |0.77       |1         |GWAS       |0.116546  |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000102755|2.0         |4.0          |\n",
      "|IL2RA         |EFO_0000574|D008223           |IL2RA-D008223  |0.538                            |Lymphoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Lymphocyte percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004632                                                                                    |2016      |null        |null    |0.079350649  |0.75     |1       |0.75       |1         |GWAS       |0.03780895|null       |oncology                                              |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |lymphoma                             |EFO_0000574|ENSG00000134460|3.0         |4.0          |\n",
      "|ERBB2         |EFO_0004142|D015179           |ERBB2-D015179  |0.035                            |Colorectal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2022       |D018655      |Lymphocyte Count                           |Genebass    |missenseLC skat continuous both_sexes irnt  |Lymphocyte percentage                                                                                     |https://genebass.org/gene/ENSG00000141736/phenotype/continuous-30180-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.00089175|null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |colorectal neoplasm                  |EFO_0004142|ENSG00000141736|3.0         |4.0          |\n",
      "|FLT4          |EFO_1001513|D008113           |FLT4-D008113   |0.535                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000037280|2.0         |4.0          |\n",
      "|PDGFRA        |EFO_0003865|D007680           |PDGFRA-D007680 |0.234                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012112                                                                                  |2020      |null        |null    |0.224016969  |0.85     |1       |0.85       |1         |GWAS       |0.0246417 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000134853|3.0         |4.0          |\n",
      "|JAK1          |EFO_0000676|D011565           |JAK1-D011565   |0.475                            |Psoriasis                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D056660      |Hereditary Autoinflammatory Diseases       |OMIM        |null                                        |Autoinflammation, immune dysregulation, and eosinophilia, 618999 (3), Autosomal dominant                  |https://omim.org/entry/147795                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |dermatology                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |psoriasis                            |EFO_0000676|ENSG00000162434|3.0         |4.0          |\n",
      "|GABRA4        |EFO_0008526|D013226           |GABRA4-D013226 |0.029                            |Status Epilepticus                    |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D000124      |Achievement                                |OTG         |null                                        |Educational attainment (MTAG) [MTAG]                                                                      |https://genetics.opentargets.org/study/GCST006571                                                                                    |2018      |null        |null    |0.291720906  |0.55     |1       |0.55       |1         |GWAS       |0.0083    |null       |neurology, signs/symptoms                             |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |TRUE       |FALSE |status epilepticus                   |EFO_0008526|ENSG00000109158|3.0         |4.0          |\n",
      "|BRAF          |EFO_1000926|D031249           |BRAF-D031249   |0.201                            |Erdheim-Chester Disease               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004476      |Ectodermal Dysplasia                       |OMIM        |null                                        |Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant                                             |https://omim.org/entry/164757                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |hematology                                            |omim/tcga      |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |Erdheim-Chester disease              |EFO_1000926|ENSG00000157764|2.0         |4.0          |\n",
      "|MAP2K2        |EFO_0004142|D015179           |MAP2K2-D015179 |0.253                            |Colorectal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D007970      |Leukopenia                                 |OTG         |null                                        |White blood cell count                                                                                    |https://genetics.opentargets.org/study/GCST007070                                                                                    |2018      |null        |null    |0.09987013   |0.6      |1       |0.6        |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |colorectal neoplasm                  |EFO_0004142|ENSG00000126934|2.0         |4.0          |\n",
      "|NR3C1         |EFO_0005628|D011349           |NR3C1-D011349  |0.461                            |Proctitis                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Gamma glutamyl transferase levels                                                                         |https://genetics.opentargets.org/study/GCST90025966                                                                                  |2021      |null        |null    |0.420228661  |0.94     |1       |0.94       |1         |GWAS       |0.0140825 |null       |digestive                                             |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |proctitis                            |EFO_0005628|ENSG00000113580|3.0         |4.0          |\n",
      "|TNFRSF8       |EFO_0002913|D016410           |TNFRSF8-D016410|0.486                            |Lymphoma, T-Cell, Cutaneous           |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Eosinophil percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004600                                                                                    |2016      |null        |null    |0.011410788  |0.64     |1       |0.64       |1         |GWAS       |0.1043421 |null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Cutaneous T-cell lymphoma            |EFO_0002913|ENSG00000120949|3.0         |4.0          |\n",
      "|CD274         |EFO_0004142|D015179           |CD274-D015179  |0.207                            |Colorectal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism                                                                                            |https://genetics.opentargets.org/study/GCST007073                                                                                    |2018      |null        |null    |0.156136482  |0.67     |1       |0.67       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |colorectal neoplasm                  |EFO_0004142|ENSG00000120217|2.0         |4.0          |\n",
      "|KIT           |EFO_0003865|D007680           |KIT-D007680    |0.534                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000157404|3.0         |4.0          |\n",
      "|PDCD1         |EFO_1001513|D008113           |PDCD1-D008113  |0                                |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2022       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000188389|2.0         |4.0          |\n",
      "|TEK           |EFO_0000222|D015470           |TEK-D015470    |0.2                              |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001165      |Arteriovenous Malformations                |OMIM        |null                                        |Venous malformations, multiple cutaneous and mucosal, 600195 (3), Autosomal dominant                      |https://omim.org/entry/600221                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000120156|2.0         |4.0          |\n",
      "|JAK1          |EFO_0002609|D001171           |JAK1-D001171   |0.265                            |Arthritis, Juvenile                   |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D009103      |Multiple Sclerosis                         |OTG         |null                                        |Multiple sclerosis                                                                                        |https://genetics.opentargets.org/study/GCST009597                                                                                    |2019      |null        |null    |0.100402388  |0.7      |1       |0.7        |1         |GWAS       |null      |1.1642     |musculoskeletal, dermatology, immune                  |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |juvenile idiopathic arthritis        |EFO_0002609|ENSG00000162434|3.0         |4.0          |\n",
      "|PARP1         |EFO_0003860|D010190           |PARP1-D010190  |0.418                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D008545      |Melanoma                                   |OTG         |null                                        |Cutaneous malignant melanoma                                                                              |https://genetics.opentargets.org/study/GCST010304                                                                                    |2020      |null        |null    |0.337015857  |0.8      |1       |0.8        |1         |GWAS       |null      |1.0947     |oncology                                              |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000143799|1.0         |4.0          |\n",
      "|APOC3         |EFO_0004211|D015228           |APOC3-D015228  |1                                |Hypertriglyceridemia                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D015228      |Hypertriglyceridemia                       |Genebass    |missenseLC burden continuous both_sexes irnt|Triglycerides                                                                                             |https://genebass.org/gene/ENSG00000110245/phenotype/continuous-30870-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full|2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.017437  |null       |metabolic                                             |both           |genetically supported target|TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Hypertriglyceridemia                 |EFO_0004211|ENSG00000110245|3.0         |4.0          |\n",
      "|IL1B          |EFO_0007135|D016706           |IL1B-D016706   |0.364                            |Still's Disease, Adult-Onset          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006967      |Hypersensitivity                           |OTG         |null                                        |Allergic disease (asthma, hay fever or eczema)                                                            |https://genetics.opentargets.org/study/GCST009716                                                                                    |2019      |null        |null    |0.354859667  |0.74     |1       |0.74       |1         |GWAS       |null      |1.0362694  |musculoskeletal, dermatology, immune                  |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |adult-onset Still's disease          |EFO_0007135|ENSG00000125538|3.0         |4.0          |\n",
      "|ERBB3         |EFO_0003060|D002289           |ERBB3-D002289  |0.22                             |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D007410      |Intestinal Diseases                        |OMIM        |null                                        |Visceral neuropathy, familial, 1, autosomal recessive, 243180 (3), Autosomal recessive                    |https://omim.org/entry/190151                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000065361|3.0         |4.0          |\n",
      "|FGFR1         |EFO_0003060|D002289           |FGFR1-D002289  |0.773                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.41128718   |0.83     |1       |0.83       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000077782|3.0         |4.0          |\n",
      "|IL1B          |EFO_0003914|D050197           |IL1B-D050197   |0.225                            |Atherosclerosis                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006967      |Hypersensitivity                           |OTG         |null                                        |Allergic disease (asthma, hay fever or eczema)                                                            |https://genetics.opentargets.org/study/GCST009716                                                                                    |2019      |null        |null    |0.354859667  |0.74     |1       |0.74       |1         |GWAS       |null      |1.0362694  |cardiovascular                                        |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |atherosclerosis                      |EFO_0003914|ENSG00000125538|3.0         |4.0          |\n",
      "|FGFR1         |EFO_0003893|D010051           |FGFR1-D010051  |0.736                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007006      |Hypogonadism                               |OMIM        |null                                        |Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3), Autosomal dominant                   |https://omim.org/entry/136350                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |ovarian neoplasm                     |EFO_0003893|ENSG00000077782|2.0         |4.0          |\n",
      "|IL23A         |EFO_0000384|D003424           |IL23A-D003424  |0                                |Crohn Disease                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |digestive                                             |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Crohn's disease                      |EFO_0000384|ENSG00000110944|3.0         |4.0          |\n",
      "|CASR          |EFO_0008519|D049950           |CASR-D049950   |0.528                            |Hyperparathyroidism, Primary          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2019       |D003924      |Diabetes Mellitus, Type 2                  |OTG         |null                                        |Type 2 diabetes                                                                                           |https://genetics.opentargets.org/study/GCST007847                                                                                    |2019      |null        |null    |0.874659401  |0.76     |1       |0.76       |1         |GWAS       |null      |1.05       |endocrine                                             |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |primary hyperparathyroidism          |EFO_0008519|ENSG00000036828|2.0         |4.0          |\n",
      "|CD3E          |EFO_0000756|D008545           |CD3E-D008545   |0.252                            |Melanoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D014923      |Wiskott-Aldrich Syndrome                   |OMIM        |null                                        |Immunodeficiency 18, 615615 (3), Autosomal recessive                                                      |https://omim.org/entry/186830                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |melanoma                             |EFO_0000756|ENSG00000198851|2.0         |4.0          |\n",
      "|NR3C1         |EFO_0004246|D009080           |NR3C1-D009080  |0.489                            |Mucocutaneous Lymph Node Syndrome     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Eosinophil percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST90002382                                                                                  |2020      |null        |null    |0.560488127  |0.6      |1       |0.6        |1         |GWAS       |0.0142986 |null       |cardiovascular, hematology, dermatology               |both           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |mucocutaneous lymph node syndrome    |EFO_0004246|ENSG00000113580|3.0         |4.0          |\n",
      "|KIT           |EFO_0003860|D010190           |KIT-D010190    |0.714                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |pancreatic neoplasm                  |EFO_0003860|ENSG00000157404|2.0         |4.0          |\n",
      "|CD274         |EFO_0000756|D008545           |CD274-D008545  |0.207                            |Melanoma                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism                                                                                            |https://genetics.opentargets.org/study/GCST007073                                                                                    |2018      |null        |null    |0.156136482  |0.67     |1       |0.67       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |melanoma                             |EFO_0000756|ENSG00000120217|3.0         |4.0          |\n",
      "|LYN           |EFO_0003060|D002289           |LYN-D002289    |0.233                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Sum neutrophil eosinophil counts                                                                          |https://genetics.opentargets.org/study/GCST004613                                                                                    |2016      |null        |null    |0.68223205   |0.85     |1       |0.85       |1         |GWAS       |0.02448989|null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000254087|2.0         |4.0          |\n",
      "|FGFR1         |EFO_0003865|D007680           |FGFR1-D007680  |0.234                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.409385756  |0.83     |1       |0.83       |1         |GWAS       |0.0201248 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000077782|2.0         |4.0          |\n",
      "|TEK           |EFO_1001513|D008113           |TEK-D008113    |0.202                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D001165      |Arteriovenous Malformations                |OMIM        |null                                        |Venous malformations, multiple cutaneous and mucosal, 600195 (3), Autosomal dominant                      |https://omim.org/entry/600221                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000120156|2.0         |4.0          |\n",
      "|F10           |EFO_0000612|D009203           |F10-D009203    |0.256                            |Myocardial Infarction                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2021       |D001778      |Blood Coagulation Disorders                |OTG         |null                                        |End-stage coagulation [FVII:C]                                                                            |https://genetics.opentargets.org/study/GCST001798_3                                                                                  |2013      |null        |null    |0.109228972  |0.69     |1       |0.69       |1         |GWAS       |0.534     |null       |cardiovascular, signs/symptoms                        |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |myocardial infarction                |EFO_0000612|ENSG00000126218|3.0         |4.0          |\n",
      "|PDCD1         |EFO_0000702|D055752           |PDCD1-D055752  |0                                |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |small cell lung carcinoma            |EFO_0000702|ENSG00000188389|3.0         |4.0          |\n",
      "|ABCB1         |EFO_0003869|D001943           |ABCB1-D001943  |0.035                            |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D049628      |Body Size                                  |OTG         |null                                        |Appendicular lean mass                                                                                    |https://genetics.opentargets.org/study/GCST90000025                                                                                  |2020      |null        |null    |0.180548337  |0.71     |1       |0.71       |1         |GWAS       |0.0158    |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000085563|2.0         |4.0          |\n",
      "|KDR           |EFO_0004230|D016889           |KDR-D016889    |0.537                            |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004715      |Endometriosis                              |OTG         |null                                        |Endometriosis                                                                                             |https://genetics.opentargets.org/study/FINNGEN_R6_N14_ENDOMETRIOSIS                                                                  |2022      |null        |null    |0.283441982  |0.9      |1       |0.9        |1         |GWAS       |null      |1.150273799|oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000128052|3.0         |4.0          |\n",
      "|PARP2         |EFO_0003860|D010190           |PARP2-D010190  |0                                |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000129484|1.0         |4.0          |\n",
      "|FLT1          |EFO_0000222|D015470           |FLT1-D015470   |0.241                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Monocyte percentage of white cells                                                                        |https://genetics.opentargets.org/study/GCST90002394                                                                                  |2020      |null        |null    |0.016874351  |0.77     |1       |0.77       |1         |GWAS       |0.116546  |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000102755|3.0         |4.0          |\n",
      "|ADRB2         |EFO_0004287|D014693           |ADRB2-D014693  |0.399                            |Ventricular Fibrillation              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2015       |D006973      |Hypertension                               |OTG         |null                                        |Diastolic blood pressure                                                                                  |https://genetics.opentargets.org/study/GCST90000059                                                                                  |2020      |null        |null    |0.011406351  |0.91     |1       |0.91       |1         |GWAS       |0.03775712|null       |cardiovascular, signs/symptoms                        |omim/tcga      |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |ventricular fibrillation             |EFO_0004287|ENSG00000169252|3.0         |4.0          |\n",
      "|FGFR1         |EFO_1001901|D018358           |FGFR1-D018358  |0.247                            |Neuroendocrine Tumors                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2021       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.409385756  |0.83     |1       |0.83       |1         |GWAS       |0.0201248 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |neuroendocrine neoplasm              |EFO_1001901|ENSG00000077782|3.0         |4.0          |\n",
      "|MAP2K1        |EFO_0003060|D002289           |MAP2K1-D002289 |0.426                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009373      |Neoplasms, Germ Cell and Embryonal         |PICCOLO     |CD4-meta-cis                                |testicular_germ_cell_tumor                                                                                |https://www.ncbi.nlm.nih.gov/pubmed/28604728                                                                                         |2017      |2.72E-20    |0.907482|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000169032|3.0         |4.0          |\n",
      "|ABCB1         |EFO_0000616|D009369           |ABCB1-D009369  |0.044                            |Neoplasms                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D049628      |Body Size                                  |OTG         |null                                        |Appendicular lean mass                                                                                    |https://genetics.opentargets.org/study/GCST90000025                                                                                  |2020      |null        |null    |0.180548337  |0.71     |1       |0.71       |1         |GWAS       |0.0158    |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |neoplasm                             |EFO_0000616|ENSG00000085563|2.0         |4.0          |\n",
      "|RET           |EFO_0003897|D013274           |RET-D013274    |0.549                            |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2014       |D013964      |Thyroid Neoplasms                          |OMIM        |null                                        |Medullary thyroid carcinoma, 155240 (3), Autosomal dominant                                               |https://omim.org/entry/164761                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |stomach neoplasm                     |EFO_0003897|ENSG00000165731|2.0         |4.0          |\n",
      "|PDCD1         |EFO_0003897|D013274           |PDCD1-D013274  |0                                |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |stomach neoplasm                     |EFO_0003897|ENSG00000188389|3.0         |4.0          |\n",
      "|KIT           |EFO_0002430|D055728           |KIT-D055728    |0.476                            |Primary Myelofibrosis                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Hemoglobin levels                                                                                         |https://genetics.opentargets.org/study/GCST004005                                                                                    |2016      |null        |null    |0.130694354  |0.83     |1       |0.83       |1         |GWAS       |null      |null       |hematology                                            |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |primary myelofibrosis                |EFO_0002430|ENSG00000157404|1.0         |4.0          |\n",
      "|BRAF          |EFO_0003865|D007680           |BRAF-D007680   |0.235                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004476      |Ectodermal Dysplasia                       |OMIM        |null                                        |Cardiofaciocutaneous syndrome, 115150 (3), Autosomal dominant                                             |https://omim.org/entry/164757                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000157764|3.0         |4.0          |\n",
      "|KDR           |EFO_0003865|D007680           |KDR-D007680    |0.516                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004715      |Endometriosis                              |OTG         |null                                        |Endometriosis                                                                                             |https://genetics.opentargets.org/study/FINNGEN_R6_N14_ENDOMETRIOSIS                                                                  |2022      |null        |null    |0.283441982  |0.9      |1       |0.9        |1         |GWAS       |null      |1.150273799|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000128052|3.0         |4.0          |\n",
      "|ERBB4         |EFO_0003897|D013274           |ERBB4-D013274  |0.567                            |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2018       |D001943      |Breast Neoplasms                           |OTG         |null                                        |Breast cancer                                                                                             |https://genetics.opentargets.org/study/GCST001457                                                                                    |2012      |null        |null    |0.088945115  |1        |1       |1          |1         |GWAS       |null      |1.53       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |stomach neoplasm                     |EFO_0003897|ENSG00000178568|1.0         |4.0          |\n",
      "|PPARA         |EFO_0003095|D065626           |PPARA-D065626  |0.198                            |Non-alcoholic Fatty Liver Disease     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |D007249      |Inflammation                               |OTG         |null                                        |CTACK levels                                                                                              |https://genetics.opentargets.org/study/GCST004420                                                                                    |2016      |null        |null    |0.717266935  |0.83     |1       |0.83       |1         |GWAS       |0.186     |null       |digestive                                             |both           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |non-alcoholic fatty liver disease    |EFO_0003095|ENSG00000186951|2.0         |4.0          |\n",
      "|C5AR1         |EFO_0006803|D014657           |C5AR1-D014657  |0                                |Vasculitis                            |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |cardiovascular                                        |both           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |vasculitis                           |EFO_0006803|ENSG00000197405|3.0         |4.0          |\n",
      "|FLT4          |EFO_0003893|D010051           |FLT4-D010051   |0.528                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000037280|2.0         |4.0          |\n",
      "|PDGFRA        |EFO_0003893|D010051           |PDGFRA-D010051 |0.599                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012112                                                                                  |2020      |null        |null    |0.224016969  |0.85     |1       |0.85       |1         |GWAS       |0.0246417 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000134853|2.0         |4.0          |\n",
      "|FGFR4         |EFO_0000702|D055752           |FGFR4-D055752  |0.759                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.307667316  |0.69     |1       |0.69       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |small cell lung carcinoma            |EFO_0000702|ENSG00000160867|2.0         |4.0          |\n",
      "|IL2RA         |EFO_0003865|D007680           |IL2RA-D007680  |0.244                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |1996       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Lymphocyte percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004632                                                                                    |2016      |null        |null    |0.079350649  |0.75     |1       |0.75       |1         |GWAS       |0.03780895|null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000134460|2.0         |4.0          |\n",
      "|RET           |EFO_0003865|D007680           |RET-D007680    |0.556                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2014       |D013964      |Thyroid Neoplasms                          |OMIM        |null                                        |Medullary thyroid carcinoma, 155240 (3), Autosomal dominant                                               |https://omim.org/entry/164761                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000165731|3.0         |4.0          |\n",
      "|BRAF          |EFO_0003893|D010051           |BRAF-D010051   |0.555                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D003924      |Diabetes Mellitus, Type 2                  |OTG         |null                                        |Type 2 diabetes                                                                                           |https://genetics.opentargets.org/study/GCST004894                                                                                    |2017      |null        |null    |0.140890793  |0.77     |1       |0.77       |1         |GWAS       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |ovarian neoplasm                     |EFO_0003893|ENSG00000157764|2.0         |4.0          |\n",
      "|RXFP1         |EFO_0003144|D006333           |RXFP1-D006333  |0                                |Heart Failure                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |cardiovascular                                        |both           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |heart failure                        |EFO_0003144|ENSG00000171509|3.0         |4.0          |\n",
      "|ANPEP         |EFO_0000222|D015470           |ANPEP-D015470  |0.226                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D008107      |Liver Diseases                             |OTG         |null                                        |Liver enzyme levels (alanine transaminase)                                                                |https://genetics.opentargets.org/study/GCST90013405                                                                                  |2021      |null        |null    |0.093737561  |0.74     |1       |0.74       |1         |GWAS       |0.00623748|null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000166825|2.0         |4.0          |\n",
      "|PDE4A         |EFO_0003780|D001528           |PDE4A-D001528  |0.218                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006967      |Hypersensitivity                           |OTG         |null                                        |Inflammatory skin disease [Psoriasis]                                                                     |https://genetics.opentargets.org/study/GCST002740_4                                                                                  |2015      |null        |null    |0.177912116  |0.54     |1       |0.54       |1         |GWAS       |null      |null       |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000065989|3.0         |4.0          |\n",
      "|FLT3          |EFO_0003841|D013964           |FLT3-D013964   |0.697                            |Thyroid Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism or myxedema                                                                                |https://genetics.opentargets.org/study/GCST90038637                                                                                  |2021      |null        |null    |0.014906027  |0.66     |1       |0.66       |1         |GWAS       |null      |1.026185264|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |thyroid neoplasm                     |EFO_0003841|ENSG00000122025|3.0         |4.0          |\n",
      "|TUBB          |EFO_0000702|D055752           |TUBB-D055752   |0.424                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006222      |Hamartoma                                  |OMIM        |null                                        |Symmetric circumferential skin creases, congenital, 1, 156610 (3), Autosomal dominant                     |https://omim.org/entry/191130                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |small cell lung carcinoma            |EFO_0000702|ENSG00000196230|3.0         |4.0          |\n",
      "|FGFR3         |EFO_0000222|D015470           |FGFR3-D015470  |0.4                              |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001749      |Urinary Bladder Neoplasms                  |PICCOLO     |gtex-v6p-adipose-subcutaneous               |bladder_cancer                                                                                            |https://www.ncbi.nlm.nih.gov/pubmed/20972438                                                                                         |2010      |6.04E-15    |0.912895|null         |null     |null    |null       |null      |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000068078|2.0         |4.0          |\n",
      "|JAK2          |EFO_0004208|D014820           |JAK2-D014820   |0.455                            |Vitiligo                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011565      |Psoriasis                                  |OTG         |null                                        |Psoriasis                                                                                                 |https://genetics.opentargets.org/study/GCST005527                                                                                    |2012      |null        |null    |0.016463573  |0.82     |1       |0.82       |1         |GWAS       |null      |8.389261745|dermatology                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |Vitiligo                             |EFO_0004208|ENSG00000096968|3.0         |4.0          |\n",
      "|FLT3          |EFO_0003865|D007680           |FLT3-D007680   |0.724                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2014       |D051437      |Renal Insufficiency                        |OTG         |null                                        |Creatinine levels                                                                                         |https://genetics.opentargets.org/study/GCST90025946                                                                                  |2021      |null        |null    |0.720277887  |0.78     |1       |0.78       |1         |GWAS       |0.0130199 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000122025|3.0         |4.0          |\n",
      "|EPHA2         |EFO_0003060|D002289           |EPHA2-D002289  |0.224                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2020       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Testosterone levels                                                                                       |https://genetics.opentargets.org/study/GCST011518                                                                                    |2021      |null        |null    |0.677792823  |0.59     |1       |0.59       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |non-small cell lung carcinoma        |EFO_0003060|ENSG00000142627|3.0         |4.0          |\n",
      "|IL17RA        |EFO_0000717|D012595           |IL17RA-D012595 |0.425                            |Scleroderma, Systemic                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D002178      |Candidiasis, Chronic Mucocutaneous         |OMIM        |null                                        |Immunodeficiency 51, 613953 (3), Autosomal recessive                                                      |https://omim.org/entry/605461                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |dermatology                                           |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |systemic scleroderma                 |EFO_0000717|ENSG00000177663|1.0         |4.0          |\n",
      "|CSNK1E        |EFO_0000095|D015451           |CSNK1E-D015451 |0.03                             |Leukemia, Lymphocytic, Chronic, B-Cell|Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D005080      |Exercise Test                              |Genebass    |pLoF skat continuous both_sexes irnt        |Maximum workload during fitness test                                                                      |https://genebass.org/gene/ENSG00000213923/phenotype/continuous-6032-both_sexes-NA-irnt?burdenSet=pLoF&phewasOpts=1&resultLayout=full |2021      |null        |null    |null         |null     |null    |null       |null      |GWAS       |0.0462    |null       |oncology                                              |both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |chronic lymphocytic leukemia         |EFO_0000095|ENSG00000213923|3.0         |4.0          |\n",
      "|FLT1          |EFO_0004230|D016889           |FLT1-D016889   |0.489                            |Endometrial Neoplasms                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011225      |Pre-Eclampsia                              |OTG         |null                                        |Preeclampsia (fetal genotype effect)                                                                      |https://genetics.opentargets.org/study/GCST90013475                                                                                  |2020      |null        |null    |0.498830257  |0.62     |1       |0.62       |1         |GWAS       |null      |1.19       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |endometrial neoplasm                 |EFO_0004230|ENSG00000102755|3.0         |4.0          |\n",
      "|PDE4D         |EFO_0003780|D001528           |PDE4D-D001528  |0.638                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D019226      |Oral Ulcer                                 |OTG         |null                                        |Mouth ulcers                                                                                              |https://genetics.opentargets.org/study/GCST007839                                                                                    |2019      |null        |null    |0.507616196  |0.92     |1       |0.92       |1         |GWAS       |null      |1.0550625  |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000113448|3.0         |4.0          |\n",
      "|ABL1          |EFO_0000222|D015470           |ABL1-D015470   |0.24                             |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007970      |Leukopenia                                 |OTG         |null                                        |White blood cell count                                                                                    |https://genetics.opentargets.org/study/GCST007070                                                                                    |2018      |null        |null    |0.373715929  |0.75     |1       |0.75       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000097007|3.0         |4.0          |\n",
      "|FGFR1         |EFO_0000702|D055752           |FGFR1-D055752  |0.759                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.41128718   |0.83     |1       |0.83       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |small cell lung carcinoma            |EFO_0000702|ENSG00000077782|2.0         |4.0          |\n",
      "|CD3E          |EFO_0005952|D008228           |CD3E-D008228   |0.515                            |Lymphoma, Non-Hodgkin                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D014923      |Wiskott-Aldrich Syndrome                   |OMIM        |null                                        |Immunodeficiency 18, 615615 (3), Autosomal recessive                                                      |https://omim.org/entry/186830                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |non-Hodgkins lymphoma                |EFO_0005952|ENSG00000198851|3.0         |4.0          |\n",
      "|CHRM4         |EFO_1000781|D053201           |CHRM4-D053201  |0.029                            |Urinary Bladder, Overactive           |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2012       |D012559      |Schizophrenia                              |PICCOLO     |gtex-v6p-nerve-tibial                       |schizophrenia                                                                                             |https://www.ncbi.nlm.nih.gov/pubmed/26198764                                                                                         |2015      |3.44E-08    |0.918717|null         |null     |null    |null       |null      |GWAS       |null      |null       |signs/symptoms                                        |gwas           |unsupported target          |TRUE        |TRUE        |TRUE       |FALSE           |FALSE |FALSE      |FALSE |overactive bladder                   |EFO_1000781|ENSG00000180720|2.0         |4.0          |\n",
      "|RET           |EFO_1001513|D008113           |RET-D008113    |0.558                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2019       |D013964      |Thyroid Neoplasms                          |OMIM        |null                                        |Medullary thyroid carcinoma, 155240 (3), Autosomal dominant                                               |https://omim.org/entry/164761                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |liver neoplasm                       |EFO_1001513|ENSG00000165731|2.0         |4.0          |\n",
      "|FLT4          |EFO_0003865|D007680           |FLT4-D007680   |0.534                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009303      |Nasopharyngeal Neoplasms                   |OTG         |null                                        |Nasopharyngeal carcinoma (SNP x SNP interaction)                                                          |https://genetics.opentargets.org/study/GCST006524                                                                                    |2013      |null        |null    |0.118917867  |0.82     |1       |0.82       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |kidney neoplasm                      |EFO_0003865|ENSG00000037280|3.0         |4.0          |\n",
      "|FGFR2         |EFO_0000702|D055752           |FGFR2-D055752  |0.759                            |Small Cell Lung Carcinoma             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D001249      |Asthma                                     |OTG         |null                                        |Lung function (FEV1/FVC)                                                                                  |https://genetics.opentargets.org/study/GCST007080                                                                                    |2018      |null        |null    |0.566796621  |0.81     |1       |0.81       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |small cell lung carcinoma            |EFO_0000702|ENSG00000066468|2.0         |4.0          |\n",
      "|KIT           |EFO_0003841|D013964           |KIT-D013964    |0.526                            |Thyroid Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D046152      |Gastrointestinal Stromal Tumors            |OMIM        |null                                        |Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated cases                  |https://omim.org/entry/164920                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |thyroid neoplasm                     |EFO_0003841|ENSG00000157404|3.0         |4.0          |\n",
      "|PDE4B         |EFO_0003780|D001528           |PDE4B-D001528  |0.629                            |Behcet Syndrome                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D005764      |Gastroesophageal Reflux                    |OTG         |null                                        |Gastroesophageal reflux disease                                                                           |https://genetics.opentargets.org/study/GCST008832                                                                                    |2019      |null        |null    |0.540398126  |0.97     |1       |0.97       |1         |GWAS       |null      |1.0328273  |ophthalmology, cardiovascular, congenital, dermatology|both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Behcet's syndrome                    |EFO_0003780|ENSG00000184588|3.0         |4.0          |\n",
      "|TUBB          |EFO_0003860|D010190           |TUBB-D010190   |0.444                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006222      |Hamartoma                                  |OMIM        |null                                        |Symmetric circumferential skin creases, congenital, 1, 156610 (3), Autosomal dominant                     |https://omim.org/entry/191130                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000196230|3.0         |4.0          |\n",
      "|MAP2K2        |EFO_0003060|D002289           |MAP2K2-D002289 |0.232                            |Carcinoma, Non-Small-Cell Lung        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007970      |Leukopenia                                 |OTG         |null                                        |White blood cell count                                                                                    |https://genetics.opentargets.org/study/GCST007070                                                                                    |2018      |null        |null    |0.09987013   |0.6      |1       |0.6        |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |non-small cell lung carcinoma        |EFO_0003060|ENSG00000126934|3.0         |4.0          |\n",
      "|PARP3         |EFO_1001100|D010534           |PARP3-D010534  |0                                |Peritoneal Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2020       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |omim/tcga      |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |peritoneal neoplasm                  |EFO_1001100|ENSG00000041880|1.0         |4.0          |\n",
      "|PIK3CD        |EFO_0000222|D015470           |PIK3CD-D015470 |0.554                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009373      |Neoplasms, Germ Cell and Embryonal         |OTG         |null                                        |Testicular germ cell tumor                                                                                |https://genetics.opentargets.org/study/GCST004635                                                                                    |2017      |null        |null    |0.418903075  |0.82     |1       |0.82       |1         |GWAS       |null      |1.14       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000171608|2.0         |4.0          |\n",
      "|IL5RA         |EFO_1000391|D009298           |IL5RA-D009298  |0.223                            |Nasal Polyps                          |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Eosinophil percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST004600                                                                                    |2016      |null        |null    |0.618628601  |0.72     |1       |0.72       |1         |GWAS       |0.02797388|null       |respiratory, signs/symptoms                           |gwas           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Nasal Cavity Polyp                   |EFO_1000391|ENSG00000091181|3.0         |4.0          |\n",
      "|IFNAR2        |EFO_0006510|D006562           |IFNAR2-D006562 |0.244                            |Herpes Zoster                         |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Eosinophil percentage of white cells                                                                      |https://genetics.opentargets.org/study/GCST90002382                                                                                  |2020      |null        |null    |0.448705992  |0.53     |1       |0.53       |1         |GWAS       |0.0138217 |null       |infection                                             |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |Herpes Zoster                        |EFO_0006510|ENSG00000159110|3.0         |4.0          |\n",
      "|JAK3          |EFO_0000676|D011565           |JAK3-D011565   |0.185                            |Psoriasis                             |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D053632      |X-Linked Combined Immunodeficiency Diseases|OMIM        |null                                        |SCID, autosomal recessive, T-negative/B-positive type, 600802 (3), Autosomal recessive                    |https://omim.org/entry/600173                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |dermatology                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |psoriasis                            |EFO_0000676|ENSG00000105639|3.0         |4.0          |\n",
      "|IL2RA         |EFO_0003869|D001943           |IL2RA-D001943  |0.494                            |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004485      |Eczema                                     |OTG         |null                                        |Eczema                                                                                                    |https://genetics.opentargets.org/study/GCST007075                                                                                    |2018      |null        |null    |0.079350649  |0.83     |1       |0.83       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |FALSE       |FALSE      |FALSE           |FALSE |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000134460|1.0         |4.0          |\n",
      "|PDCD1         |EFO_0003869|D001943           |PDCD1-D001943  |0                                |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000188389|3.0         |4.0          |\n",
      "|PDGFRB        |EFO_0003860|D010190           |PDGFRB-D010190 |0.367                            |Pancreatic Neoplasms                  |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D018224      |Myofibromatosis                            |OMIM        |null                                        |Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant                                             |https://omim.org/entry/173410                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |pancreatic neoplasm                  |EFO_0003860|ENSG00000113721|2.0         |4.0          |\n",
      "|PDGFRB        |EFO_0003893|D010051           |PDGFRB-D010051 |0.367                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D018224      |Myofibromatosis                            |OMIM        |null                                        |Myofibromatosis, infantile, 1, 228550 (3), Autosomal dominant                                             |https://omim.org/entry/173410                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000113721|2.0         |4.0          |\n",
      "|CSF1R         |EFO_0003865|D007680           |CSF1R-D007680  |0.244                            |Kidney Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Granulocyte percentage of myeloid white cells                                                             |https://genetics.opentargets.org/study/GCST004608                                                                                    |2016      |null        |null    |0.633411581  |0.58     |1       |0.58       |1         |GWAS       |0.03435342|null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |kidney neoplasm                      |EFO_0003865|ENSG00000182578|3.0         |4.0          |\n",
      "|ALOX5         |EFO_0000341|D029424           |ALOX5-D029424  |0.224                            |Pulmonary Disease, Chronic Obstructive|Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2007       |D000740      |Anemia                                     |OTG         |null                                        |Mean corpuscular hemoglobin                                                                               |https://genetics.opentargets.org/study/GCST007068                                                                                    |2018      |null        |null    |0.202936209  |0.64     |1       |0.64       |1         |GWAS       |null      |null       |respiratory                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |chronic obstructive pulmonary disease|EFO_0000341|ENSG00000012779|3.0         |4.0          |\n",
      "|FGFR1         |EFO_0000222|D015470           |FGFR1-D015470  |0.232                            |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012113                                                                                  |2020      |null        |null    |0.409385756  |0.83     |1       |0.83       |1         |GWAS       |0.0201248 |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |acute myeloid leukemia               |EFO_0000222|ENSG00000077782|2.0         |4.0          |\n",
      "|EZH2          |EFO_0005952|D008228           |EZH2-D008228   |0.455                            |Lymphoma, Non-Hodgkin                 |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |D000740      |Anemia                                     |OTG         |null                                        |Red cell distribution width                                                                               |https://genetics.opentargets.org/study/GCST007074                                                                                    |2018      |null        |null    |0.474047092  |0.77     |1       |0.77       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |non-Hodgkins lymphoma                |EFO_0005952|ENSG00000106462|1.0         |4.0          |\n",
      "|F10           |EFO_1000985|D000789           |F10-D000789    |0.227                            |Angina, Unstable                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |2021       |D001778      |Blood Coagulation Disorders                |OTG         |null                                        |End-stage coagulation [FVII:C]                                                                            |https://genetics.opentargets.org/study/GCST001798_3                                                                                  |2013      |null        |null    |0.109228972  |0.69     |1       |0.69       |1         |GWAS       |0.534     |null       |cardiovascular, signs/symptoms                        |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |intermediate coronary syndrome       |EFO_1000985|ENSG00000126218|3.0         |4.0          |\n",
      "|TOP2A         |EFO_0000174|D012512           |TOP2A-D012512  |0                                |Sarcoma, Ewing                        |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |Ewing sarcoma                        |EFO_0000174|ENSG00000131747|3.0         |4.0          |\n",
      "|FLT1          |EFO_0003893|D010051           |FLT1-D010051   |0.505                            |Ovarian Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D011225      |Pre-Eclampsia                              |OTG         |null                                        |Preeclampsia (fetal genotype effect)                                                                      |https://genetics.opentargets.org/study/GCST90013475                                                                                  |2020      |null        |null    |0.498830257  |0.62     |1       |0.62       |1         |GWAS       |null      |1.19       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |ovarian neoplasm                     |EFO_0003893|ENSG00000102755|2.0         |4.0          |\n",
      "|NR3C1         |EFO_0003872|D003092           |NR3C1-D003092  |0.513                            |Colitis                               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |1999       |D008107      |Liver Diseases                             |OTG         |null                                        |Gamma glutamyl transferase levels                                                                         |https://genetics.opentargets.org/study/GCST90025966                                                                                  |2021      |null        |null    |0.420228661  |0.94     |1       |0.94       |1         |GWAS       |0.0140825 |null       |digestive                                             |gwas           |unsupported target          |FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |colitis                              |EFO_0003872|ENSG00000113580|3.0         |4.0          |\n",
      "|PPARA         |EFO_0001073|D009765           |PPARA-D009765  |1                                |Obesity                               |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D009765      |Obesity                                    |OTG         |null                                        |Weight                                                                                                    |https://genetics.opentargets.org/study/GCST90018729                                                                                  |2021      |null        |null    |0.203619616  |0.55     |1       |0.55       |1         |GWAS       |0.0349198 |null       |metabolic, signs/symptoms                             |both           |genetically supported target|FALSE       |TRUE        |FALSE      |TRUE            |FALSE |FALSE      |FALSE |obesity                              |EFO_0001073|ENSG00000186951|2.0         |4.0          |\n",
      "|HDAC10        |EFO_0003869|D001943           |HDAC10-D001943 |0                                |Breast Neoplasms                      |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |null         |null                                       |null        |null                                        |null                                                                                                      |null                                                                                                                                 |null      |null        |null    |null         |null     |null    |null       |null      |null       |null      |null       |oncology                                              |both           |unsupported target          |FALSE       |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |breast neoplasm                      |EFO_0003869|ENSG00000100429|1.0         |4.0          |\n",
      "|PDGFRA        |EFO_1001513|D008113           |PDGFRA-D008113 |0.235                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D004700      |Endocrine System Diseases                  |OTG         |null                                        |Total testosterone levels                                                                                 |https://genetics.opentargets.org/study/GCST90012112                                                                                  |2020      |null        |null    |0.224016969  |0.85     |1       |0.85       |1         |GWAS       |0.0246417 |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000134853|2.0         |4.0          |\n",
      "|JAK1          |EFO_0004208|D014820           |JAK1-D014820   |0.455                            |Vitiligo                              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |null       |D056660      |Hereditary Autoinflammatory Diseases       |OMIM        |null                                        |Autoinflammation, immune dysregulation, and eosinophilia, 618999 (3), Autosomal dominant                  |https://omim.org/entry/147795                                                                                                        |null      |null        |null    |null         |null     |null    |null       |null      |OMIM       |null      |null       |dermatology                                           |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |TRUE  |Vitiligo                             |EFO_0004208|ENSG00000162434|3.0         |4.0          |\n",
      "|CD274         |EFO_0003897|D013274           |CD274-D013274  |0.2                              |Stomach Neoplasms                     |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |TRUE  |2021       |D007037      |Hypothyroidism                             |OTG         |null                                        |Hypothyroidism                                                                                            |https://genetics.opentargets.org/study/GCST007073                                                                                    |2018      |null        |null    |0.156136482  |0.67     |1       |0.67       |1         |GWAS       |null      |null       |oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |stomach neoplasm                     |EFO_0003897|ENSG00000120217|2.0         |4.0          |\n",
      "|FLT1          |EFO_1001513|D008113           |FLT1-D008113   |0.246                            |Liver Neoplasms                       |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D006402      |Hematologic Diseases                       |OTG         |null                                        |Monocyte percentage of white cells                                                                        |https://genetics.opentargets.org/study/GCST90002394                                                                                  |2020      |null        |null    |0.016874351  |0.77     |1       |0.77       |1         |GWAS       |0.116546  |null       |oncology                                              |gwas           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |FALSE |FALSE      |FALSE |liver neoplasm                       |EFO_1001513|ENSG00000102755|2.0         |4.0          |\n",
      "|BCR           |EFO_0000222|D015470           |BCR-D015470    |0.03                             |Leukemia, Myeloid, Acute              |Launched            |Launched        |Launched          |TRUE    |TRUE    |TRUE    |TRUE    |FALSE |null       |D007839      |Functional Laterality                      |OTG         |null                                        |Left-handedness                                                                                           |https://genetics.opentargets.org/study/GCST90013421                                                                                  |2020      |null        |null    |0.597516578  |0.66     |1       |0.66       |1         |GWAS       |null      |1.022348476|oncology                                              |both           |unsupported target          |TRUE        |TRUE        |FALSE      |FALSE           |TRUE  |FALSE      |FALSE |acute myeloid leukemia               |EFO_0000222|ENSG00000186716|3.0         |4.0          |\n",
      "+--------------+-----------+------------------+---------------+---------------------------------+--------------------------------------+--------------------+----------------+------------------+--------+--------+--------+--------+------+-----------+-------------+-------------------------------------------+------------+--------------------------------------------+----------------------------------------------------------------------------------------------------------+-------------------------------------------------------------------------------------------------------------------------------------+----------+------------+--------+-------------+---------+--------+-----------+----------+-----------+----------+-----------+------------------------------------------------------+---------------+----------------------------+------------+------------+-----------+----------------+------+-----------+------+-------------------------------------+-----------+---------------+------------+-------------+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "### cases where Nelson is Phase 4 and Chembl below 4\n",
    "\n",
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 4.0) & (F.col(\"maxClinPhase\") < 4.0)\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+-------------------------------------+-----+\n",
      "|label                                |count|\n",
      "+-------------------------------------+-----+\n",
      "|non-small cell lung carcinoma        |14   |\n",
      "|kidney neoplasm                      |14   |\n",
      "|liver neoplasm                       |13   |\n",
      "|acute myeloid leukemia               |11   |\n",
      "|pancreatic neoplasm                  |10   |\n",
      "|ovarian neoplasm                     |9    |\n",
      "|stomach neoplasm                     |7    |\n",
      "|breast neoplasm                      |6    |\n",
      "|small cell lung carcinoma            |6    |\n",
      "|Behcet's syndrome                    |5    |\n",
      "|endometrial neoplasm                 |5    |\n",
      "|status epilepticus                   |4    |\n",
      "|non-Hodgkins lymphoma                |4    |\n",
      "|colorectal neoplasm                  |4    |\n",
      "|ventricular fibrillation             |3    |\n",
      "|thyroid neoplasm                     |3    |\n",
      "|melanoma                             |3    |\n",
      "|Vitiligo                             |2    |\n",
      "|chronic lymphocytic leukemia         |2    |\n",
      "|primary myelofibrosis                |2    |\n",
      "|psoriasis                            |2    |\n",
      "|obesity                              |2    |\n",
      "|ankylosing spondylitis               |2    |\n",
      "|idiopathic pulmonary fibrosis        |2    |\n",
      "|myocardial infarction                |2    |\n",
      "|non-alcoholic fatty liver disease    |2    |\n",
      "|psoriatic arthritis                  |2    |\n",
      "|juvenile idiopathic arthritis        |2    |\n",
      "|overactive bladder                   |2    |\n",
      "|Nasal Cavity Polyp                   |2    |\n",
      "|neuroblastoma                        |2    |\n",
      "|lymphoma                             |2    |\n",
      "|pituitary-dependent Cushing's disease|2    |\n",
      "|rheumatoid arthritis                 |2    |\n",
      "|neoplasm                             |1    |\n",
      "|Erdheim-Chester disease              |1    |\n",
      "|Hodgkins lymphoma                    |1    |\n",
      "|atherosclerosis                      |1    |\n",
      "|adult-onset Still's disease          |1    |\n",
      "|Mastocytosis                         |1    |\n",
      "|colitis                              |1    |\n",
      "|Crohn's disease                      |1    |\n",
      "|Hypertriglyceridemia                 |1    |\n",
      "|heart failure                        |1    |\n",
      "|cardiovascular disease               |1    |\n",
      "|diabetic nephropathy                 |1    |\n",
      "|diffuse large B-cell lymphoma        |1    |\n",
      "|mucocutaneous lymph node syndrome    |1    |\n",
      "|Herpes Zoster                        |1    |\n",
      "|multiple myeloma                     |1    |\n",
      "|polycythemia vera                    |1    |\n",
      "|medulloblastoma                      |1    |\n",
      "|Sjogren syndrome                     |1    |\n",
      "|nasopharyngeal neoplasm              |1    |\n",
      "|Cutaneous T-cell lymphoma            |1    |\n",
      "|proctitis                            |1    |\n",
      "|neuroendocrine neoplasm              |1    |\n",
      "|nicotine dependence                  |1    |\n",
      "|anemia (phenotype)                   |1    |\n",
      "|dry eye syndrome                     |1    |\n",
      "|irritable bowel syndrome             |1    |\n",
      "|vasculitis                           |1    |\n",
      "|chronic obstructive pulmonary disease|1    |\n",
      "|sinusitis                            |1    |\n",
      "|brain neoplasm                       |1    |\n",
      "|peritoneal neoplasm                  |1    |\n",
      "|lipodystrophy                        |1    |\n",
      "|Ewing sarcoma                        |1    |\n",
      "|intermediate coronary syndrome       |1    |\n",
      "|benign prostatic hyperplasia         |1    |\n",
      "|systemic scleroderma                 |1    |\n",
      "|leukemia                             |1    |\n",
      "|primary hyperparathyroidism          |1    |\n",
      "|infection                            |1    |\n",
      "+-------------------------------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "### Diseases from cases where Nelson is Phase 4 and Chembl below 2\n",
    "\n",
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 4.0) & (F.col(\"maxClinPhase\") < 4.0)\n",
    ").groupBy(\n",
    "    \"label\"\n",
    ").count().sort(\n",
    "    F.col(\"count\").desc()\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "data": {
      "text/plain": [
       "195"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 4.0) & (F.col(\"maxClinPhase\") < 4.0)\n",
    ").count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "                                                                                \r"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+--------------+-----+\n",
      "|approvedSymbol|count|\n",
      "+--------------+-----+\n",
      "|FGFR1         |8    |\n",
      "|FLT1          |7    |\n",
      "|KIT           |6    |\n",
      "|BRAF          |6    |\n",
      "|FGFR3         |6    |\n",
      "|PDCD1         |6    |\n",
      "|IL2RA         |5    |\n",
      "|KDR           |5    |\n",
      "|FLT4          |5    |\n",
      "|TOP2A         |5    |\n",
      "|CD274         |4    |\n",
      "|BTK           |4    |\n",
      "|RET           |4    |\n",
      "|PDGFRA        |4    |\n",
      "|FGFR2         |4    |\n",
      "|ABCB1         |4    |\n",
      "|NR3C1         |4    |\n",
      "|VEGFA         |3    |\n",
      "|PDGFRB        |3    |\n",
      "|IL17RA        |3    |\n",
      "|JAK1          |3    |\n",
      "|FGFR4         |3    |\n",
      "|FLT3          |3    |\n",
      "|IL1B          |2    |\n",
      "|IL17F         |2    |\n",
      "|ERBB4         |2    |\n",
      "|F10           |2    |\n",
      "|TUBB          |2    |\n",
      "|CD3E          |2    |\n",
      "|PIK3CD        |2    |\n",
      "|PPARA         |2    |\n",
      "|CSF1R         |2    |\n",
      "|IL4R          |2    |\n",
      "|APOC3         |2    |\n",
      "|JAK3          |2    |\n",
      "|TEK           |2    |\n",
      "|MAP2K2        |2    |\n",
      "|MAP2K1        |2    |\n",
      "|LYN           |2    |\n",
      "|CHRM1         |1    |\n",
      "|TOP1          |1    |\n",
      "|EZH2          |1    |\n",
      "|CYP11B2       |1    |\n",
      "|CD19          |1    |\n",
      "|GABRA4        |1    |\n",
      "|IFNAR2        |1    |\n",
      "|PLG           |1    |\n",
      "|CHRM4         |1    |\n",
      "|PDE4B         |1    |\n",
      "|IL6           |1    |\n",
      "|IFNG          |1    |\n",
      "|NR1H4         |1    |\n",
      "|OPRD1         |1    |\n",
      "|PARP1         |1    |\n",
      "|CD276         |1    |\n",
      "|JAK2          |1    |\n",
      "|SCN3A         |1    |\n",
      "|TGFB1         |1    |\n",
      "|TNFRSF8       |1    |\n",
      "|SCN5A         |1    |\n",
      "|PLAT          |1    |\n",
      "|ERBB2         |1    |\n",
      "|RXFP1         |1    |\n",
      "|FKBP1A        |1    |\n",
      "|CASR          |1    |\n",
      "|HDAC10        |1    |\n",
      "|EPHA2         |1    |\n",
      "|PARP2         |1    |\n",
      "|C5AR1         |1    |\n",
      "|ANPEP         |1    |\n",
      "|PPARG         |1    |\n",
      "|ADRB1         |1    |\n",
      "|BCR           |1    |\n",
      "|CSNK1E        |1    |\n",
      "|TYMS          |1    |\n",
      "|IL5RA         |1    |\n",
      "|ADRB2         |1    |\n",
      "|PDE4C         |1    |\n",
      "|SCN1A         |1    |\n",
      "|TNF           |1    |\n",
      "|ALOX5         |1    |\n",
      "|IFNAR1        |1    |\n",
      "|EGFR          |1    |\n",
      "|SCN2A         |1    |\n",
      "|IL23A         |1    |\n",
      "|GNRHR         |1    |\n",
      "|ABL1          |1    |\n",
      "|BCL2          |1    |\n",
      "|CNR1          |1    |\n",
      "|CSF3R         |1    |\n",
      "|RAF1          |1    |\n",
      "|SLC5A2        |1    |\n",
      "|PARP3         |1    |\n",
      "|PDE4A         |1    |\n",
      "|AR            |1    |\n",
      "|ERBB3         |1    |\n",
      "|PDE4D         |1    |\n",
      "+--------------+-----+\n",
      "\n"
     ]
    }
   ],
   "source": [
    "### Targets from cases where Nelson is Phase 4 and Chembl below 2\n",
    "\n",
    "matches.withColumn(\n",
    "    \"combinedPhase\",\n",
    "    F.when(F.col(\"combined_max_phase\") == \"Preclinical\", F.lit(0.5))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase I\", F.lit(1.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase II\", F.lit(2.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Phase III\", F.lit(3.0))\n",
    "    .when(F.col(\"combined_max_phase\") == \"Launched\", F.lit(4.0)),\n",
    ").filter(F.col(\"combinedPhase\").isNotNull() & F.col(\"maxClinPhase\").isNotNull()).filter(\n",
    "    (F.col(\"combinedPhase\") == 4.0) & (F.col(\"maxClinPhase\") < 4.0)\n",
    ").groupBy(\n",
    "    \"approvedSymbol\"\n",
    ").count().sort(\n",
    "    F.col(\"count\").desc()\n",
    ").show(\n",
    "    309, truncate=False\n",
    ")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "PySpark",
   "language": "python",
   "name": "pyspark"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.8"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
